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ABSTRACT 
 
SULFORAPHANE PROTECTS AGAINST ETHANOL-INDUCED APOPTOSIS 
AND TERATOGENESIS THROUGH EPIGENETIC MODULATION OF ANTI-
APOPTOTIC GENES 
 
Yihong Li 
April 3, 2020 
Background. Ethanol-induced excessive apoptosis in neural crest cells (NCCs), 
a multipotent progenitor cell population, is one of the major mechanisms underlying 
the pathogenesis of Fetal Alcohol Spectrum Disorders (FASD). However, the 
molecular mechanisms underlying FASD that results from maternal alcohol 
exposure during pregnancy are poorly understood. The overall goals of this study 
are to examine the mechanisms by which ethanol induces apoptosis and 
malformations in vitro and in vivo, and to develop a nutritional-based approach by 
using SFN and SFN-rich BSE to prevent FASD through epigenetic modulation. 
Results.  This study demonstrates that ethanol exposure resulted in a significant 
increase in the DNMT activity and the expression of DNMT3a in human neural 
vii 
 
crest cells. SFN can significantly diminish ethanol-induced increases in DNMT 
activity and the expression of DNMT3a.  We have also found that ethanol-induced 
up-regulation of DNMT3a and an increase in DNMT activity resulted in 
hypermethylation at the promoters of the selected anti-apoptotic genes and that 
SFN can diminish ethanol-induced hypermethylation at the promoters of the anti-
apoptotic genes by preventing ethanol-induced up-regulation of DNMT3a and 
increase in DNMT activity. In addition, the knockdown of DNMT3a or treatment 
with SFN significantly diminished ethanol-induced decreases in the mRNA and 
protein expression of NAIP and XIAP and prevented ethanol-induced apoptosis in 
human neural crest cells. The knockdown of DNMT3a also enhanced the effects 
of SFN on the mRNA and protein expression of NAIP and XIAP and the protective 
effects of SFN on ethanol-induced apoptosis. This study also shows that ethanol 
exposure can increase HDAC activity and the expression of HDAC2 in human 
neural crest cells. SFN treatment significantly diminished ethanol-induced increase 
in HDAC activity and the up-regulation of HDAC2. We have also found that 
ethanol-induced increase in HDAC activity and up-regulation of HDAC2 resulted 
in the reduction of H3 acetylation at the promoters of AKT1, BIRC6 and XIAP and 
that SFN diminished ethanol-induced reduction of H3 acetylation at the promoters 
of anti-apoptotic genes by inhibiting HDAC activity and reducing ethanol-induced 
up-regulation of HDAC2. In addition, SFN treatment or knockdown of HDAC2 
significantly diminished ethanol-induced decreases in the mRNA and protein 
expression of AKT1, BIRC6 and XIAP and prevented ethanol-induced apoptosis 
in human neural crest cells. The knockdown of HDAC2 also enhanced the effects 
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of SFN on the mRNA and protein expression of AKT1, BIRC6 and XIAP and the 
protection against ethanol-induced apoptosis.   In addition, our studies have shown 
that ethanol exposure can inhibit EMT through the down-regulation of Snail1 by 
decreasing H3K4me3 enrichment at the promoter regions of Snail1 and increase 
apoptosis in neural crest cells. SFN treatment can reverse the ethanol-induced 
reduction of the H3K4me3 enrichment at the promoter regions of Snail1, restore 
the expression of Snail1 and EMT in neural crest cells exposed to ethanol and 
diminished ethanol-induced apoptosis. These findings demonstrate that the 
disruption of EMT contributes to ethanol-induced apoptosis in neural crest cells 
and that SFN can prevent ethanol-induced apoptosis by restoring EMT through 
epigenetically regulating the expression of EMT-related genes, suggesting that 
elucidation of Snail1’s role in EMT and ethanol-induced apoptosis in neural crest 
cells may provide critical insight into the pathogenesis of FASD. Moreover, this 
study has demonstrated that SFN-rich BSE can attenuate ethanol-induced 
teratogenesis through epigenetically up-regulating the anti-apoptotic genes. 
Conclusions. The findings from work presented in this dissertation provide critical 
insight into the pathogenesis of FASD. In addition, the potency of SFN in 
preventing ethanol-induced apoptosis illustrates the potential of a practical and 
promising therapeutic strategy for FASD.
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CHAPTER I 
 
INTRODUCTION 
 
 Background  
 FASD and ethanol-induced apoptosis in NCCs 
           Fetal alcohol spectrum disorder (FASD) is one of the most common birth 
defects caused by maternal drinking alcohol during pregnancy. The recent meta-
analysis estimated that the worldwide prevalence of FASD is approximately 7.7 
per 1000 population1. The World Health Organization (WHO) European region had 
the highest prevalence of FASD, which is 19.8 per 1000 population1. In the United 
States, the active case ascertainment studies estimated that 1.1 to 4.8% of school-
aged children might have FASD2. FASD is one of the major public health problems 
in this country and in the world.   
           FASD is characterized by craniofacial abnormalities, including narrow 
forehead, short palpebral fissures, elongated upper lip, upturned nose and 
deficient philtrum. In addition of the craniofacial dysmorphology, the long-term 
consequences of prenatal alcohol exposure include mental retardation, growth 
retardation, cognitive deficits and social problems. A number of animal models of 
prenatal alcohol exposure have been used to elucidate the mechanisms 
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underlying the teratogenic effect of alcohol3-7. A number of studies have 
demonstrated that the teratogenesis caused by ethanol is, at least in part, 
mediated by excessive cell death in selected cell populations8. Among these, the 
neural crest cells (NCCs) are one of the most vulnerable cell populations to ethanol 
stimuli during the embryo development9. NCCs is a cell population that arises at 
the border of the non-neural ectoderm and the neural plate at the end of 
gastrulation. This border, also known as neural fold, flanks the neural plate 
bilaterally. During neurulation, the neural plate closes and brings together the 
neural folds at the dorsal midline. Subsequently, NCCs go through the epithelial-
to-mesenchymal transition (EMT), allowing them to delaminate from the 
neuroepithelium and to migrate ventrally and differentiate into various cell types10. 
In the cranial region, the neural crest gives rise to the majority of the skull and facial 
skeleton, teeth, cartilage, tendons, smooth muscles, dermis and melanocytes as 
well as neurons and glia of the cranial ganglia11-13. Studies by Kotch and Sulik, as 
well as  Dunty et al. have shown that ethanol exposure during gastrulation and/ or 
neurulation resulted in massive cell apoptosis in hindbrain neuroepithelium as well 
as other cell populations including NCCs14. The study by Rovasio has also 
indicated that ethanol exposure could induce morphological and dynamic changes 
in NCCs in vivo and in vitro15. In addition, study also suggested that ethanol may 
directly interfere with the earliest neural crest formation by downregulation of the 
inducers of neural crest, which subsequently causes apoptosis in the neural crest16. 
The previous studies from our group have also demonstrated that ethanol 
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significantly increased apoptosis in NCCs17-19, and that ethanol-induced apoptosis 
in NCCs contributes significantly to the ethanol-induced malformation. 
 Epigenetic regulation and FASD 
           Epigenetics can be defined as heritable changes in gene expression without 
alteration in the DNA sequences. The epigenetic modifications generally include 
DNA methylation and histone modification, of which histone can be modified by 
methylation and acetylation. Both DNA methylation and histone modification can 
alter the accessibility of double strands of DNA to the molecular transcriptional 
machinery. Epigenetic regulation can be interfered with by ethanol, leading to 
aberrant gene expression and subsequently contributing to the abnormal fetal 
development20, 21.  
           Using animal models of FASD, substantial studies have reported that the 
epigenetic alternations, including DNA methylation22-24 and histone modification25-
29, are involved in the detrimental effects of prenatal alcohol exposure and 
contribute to the abnormalities associated with FASD. A study by Garro has shown 
that epigenetic modifications may occur after ethanol exposure during embryonic 
development through hypermethylation of fetal DNA, which may contribute to 
abnormalities in FASD30.  Liu et al. found that extensive methylation occurred in 
the developmental genes in alcohol-exposed mouse embryos20.  Study has also 
shown that exposure to alcohol increased the probability of transcriptional silencing 
of the Avy gene in early fetal development31. In addition, it was reported that 
prenatal alcohol exposure resulted in alterations in DNA methylation in mice and 
consequently led to craniofacial and growth defects that are paralleled to FASD in 
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humans. Zhou and colleagues have also demonstrated that DNA methylation in 
the developing nervous system were disturbed by alcohol, leading to 
hypermethylation and the repression of the genes, particularly in the genes 
involved in neural tube development32, 33. Moreover, the enhanced methylation 
was found in imprinted genes, which are essential for cell cycle, growth, apoptosis, 
cancer and in a significant number of genes essential for olfaction20. These results 
indicated that the ethanol-induced alterations in DNA methylation contribute to the 
pathogenesis of FASD.  
           In addition to DNA methylation, histone modifications also play an important 
role in ethanol-induced apoptosis and the pathogenesis of FASD. The earliest 
study on the effects of ethanol on histone modifications was conducted on liver 
cells.  This study has demonstrated that H3K4ac was increased in a time and dose-
dependent manner in liver cells exposed to ethanol34. It was also reported that 
acute alcohol exposure in mice resulted in a strong increase in H3K9me2 and 
H3K9ac levels at GD7 and reduced H3K27me3 levels at GD17 and that these 
histone modifications correlated with the craniofacial development and the CNS 
defects. In the offspring of the alcohol-exposed mice, the H3K4me2 and H3K4me3 
were reduced significantly while both acetylated H3K9 and H3K9me2 were 
increased35. Consistent with acetylated or methylated histone H3 and H4, the 
transcriptional activity of enzymes responsible for gene expression were also 
changed36. Those epigenetic changes can persist long after the transient ethanol 
signal has disappeared, highlighting the particular importance of this phenomenon 
for FASD. 
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 DNA methylation and apoptosis 
           During embryonic and fetal development, the epigenetic markers (including 
DNA methylation and histone modification) are well established, and its status at 
some genomic loci is labile and changes in response to environmental exposure, 
including diet and alcohol37. DNA methylation occurs on the cytosine residue of 
CpG dinucleotides and is performed by DNA methyltransferases (DNMTs) through 
the transfer of 5-methylcytosine from the methyl donor S-adenosylmethionine 
(SAM) to the CpG. Three DNMTs (DNMT1, DNMT3a, DNMT3b) are required for 
the establishment and maintenance of DNA methylation patterns. DNMT1 is 
responsible for the maintenance of established patterns of DNA methylation, while 
DNMT3a and DNMT3b mediate the establishment of new or de novo DNA 
methylation patterns and play essential roles during embryonic development38. In 
mammal, DNA methylation is globally distributed in CpG islands throughout the 
entire genome, which are areas rich in CpG dinucleotides and typically located 
near the promoter region of genes. Alteration of the DNMT level may trigger hyper-
methylation or hypo-methylation of gene promoters, which could consequently 
result in inhibiting or activating gene expression, respectively. Evidence from 
literature indicates that the DNA methylation-mediated regulation of gene 
expression is involved in apoptosis, which is an important mechanism through 
which tumor cells avoid apoptosis39, 40. These changes can occur either in the form 
of hypomethylation to reactivate anti-apoptotic genes or hypermethylation to 
repress pro-apoptotic genes40. A study by Pompeia et al. showed that aberrant 
methylation by DNMT inhibitor zebularine promoted the expression of some pro-
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apoptotic genes (BAD, BAK, BIK and BAX), contributing to growth and survival of 
multiple myeloma cells41. The other studies indicated that hypermethylation of the 
pro-apoptotic gene Fas in T-cell lymphoma or in colon carcinoma cell lines 
correlated to a decrease in Fas expression, thus conferring resistance to 
apoptosis42-44, whereas DNMT inhibitor 5-aza-2’-deoxycytidine (5-azadC) can 
reverse this effect. Similarly, a study that analyzed the methylation status of pro-
apoptotic gene BNIP3 indicated that the methylation level correlated inversely with 
gene expression and also with the reduction of apoptosis45. In addition, it has been 
shown that the loss of methylation in the inhibitor apoptosis protein (IAP) promoters 
might be related to apoptosis resistance39. Strikingly, Survivin, which is normally 
expressed during embryonic development, has been found to be hypomethylated 
by DNMT inhibitor and  highly overexpressed  in different cancers including ovarian, 
HCC (Hepato cellular carcinoma) and glioma, conferring resistance to apoptosis39, 
46.  A positive  correlation between DNMT1 levels and Survivin methylation status 
suggested that DNMT1 is required for Survivin regulation47. These studies 
demonstrate that alterations of methylation at the promoters of apoptotic genes 
are associated with apoptosis.   
 Histone acetylation and apoptosis 
           Histone modification is one of the major epigenetic modifications. Histone 
modifications play a crucial role in many cellular processes during embryonic 
development, including cell proliferation, cell survival and cellular differentiation48. 
In eukaryotic cells, DNA forms a complex structure with proteins called chromatin. 
In chromatin, the fundamental repeat unit is the chromosome, consisting of one 
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octamer comprised of four core histone proteins (H2A, H2B, H3, and H4) around 
which 147 base pairs of DNA are wrapped48, 49. Chromatin modifications also 
shape the epigenome and regulate gene expression in both normal and cancer 
cells50. Each of the core histones has an N-terminal “tail” that can be subject to 
several covalent modifications associated with euchromatic (open) and 
heterochromatic (closed) chromatin states. These covalent modifications are 
established by “writers”, such as histone lysine methyltransferase (KMTs), histone 
acetyltransferases (HATs). These modifications can be removed by “erasers”, 
such as histone demethylases (KDMs), histone deacetylases (HDACs)51. HATs 
and HDACs are associated with histone acetylation and deacetylation, 
respectively. There are 18 HDACs in humans, and they are distributed into 4 
classes: Class I HDACs include HDACs 1, 2, 3 and 8, which are located in the 
nucleus. Class I HDACs were reported to regulate neurogenesis, proliferation, 
differentiation, and embryonic development52-54. Class II HDACs include HDAC 4, 
5, 9, and 10 (Class IIa) as well as HDACs 6 and 10 (Class IIb), which are localized 
both in the nucleus and the cytoplasm. Class III HDACs comprise SIRTs 1 to 7, 
and class IV is formed by HDAC11 only55. Both HATs and HDACs regulate the 
dynamic acetylation balance of histone and nonhistone proteins and play an 
important role in cell proliferation, apoptosis, differentiation, cancer treatment, 
neuroprotection, and anti-inflammatory effects56-58. The histone deacetylase 
inhibitor (HDACi) can interfere with the deacetylase function of HDACs, improve 
the acetylation level of histone, and regulate gene expression. Histone acetylation 
is associated with activation of transcription. Active genes usually carry high levels 
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of lysine acetylation on histone H3 (H3ac) and h4 (H4ac). Moreover, histone H3 
lysine acetylation at position 9 (H3K9Ac) and 14 (H3K14Ac) is associated with 
open chromatin at the gene promoter region and activate gene expression. 
Substantial studies have shown that the HDACis are emerging as a prominent 
class of therapeutic agents for treatment of a variety of cancers, such as pancreatic, 
ovarian, breast, colon, prostate, and thyroid cancer59-63. Other studies have also 
demonstrated that HDACi has important neuroprotective effects in the treatment 
of diseases of nervous system64-67. HDACi are known to inhibit apoptosis, increase 
cell survival and enhance anti-inflammatory response64, 65, 68, 69. The study by Dr. 
Chuang group showed that HDACi Trichostatin A (TSA) can regulate the 
expression of apoptosis-related genes Bcl2 and apaf-1 and improve neurological 
performance in the rat permanent middle cerebral artery occlusion (pMCAO) 
model of stoke65. Valproic acid (VPA), another HDACi, can also attenuate retinal 
neuron apoptosis by inhibiting the activation of caspase 3 and the apoptotic 
protease activating factor-1 (apaf-1), and the release of cytochrome C68. It has also 
been demonstrated that HDACi increased the acetylation of histone H3, activated 
the transcription of downstream genes Akt, Erk, CREB and HSP70, and thus 
upregulated the levels of anti-apoptotic proteins Bcl-2 and Bcl-xL, and eventually 
led to the downregulation of caspase-365, 70. In addition, a study from Dr. Zhang 
shown that VPA protects against neuronal apoptosis by activation of BNDF-TrkB 
signaling at the transcriptional levels and that VPA treatment resulted in the 
hyperacetylation of histone H3K14, attenuated histone H3K9 hypermethylation in 
the BNDF promoter, and promoted transcriptional activity71. A study from this 
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group has also demonstrated that VPA upregulated the expression of the anti-
apoptotic gene Hsp70 by enhancing the acetylation of histone H3 at Hsp70 
promoter68.  Our recent study has shown sulforaphane (SFN), a well-known HDACi,  
restored the expression of the anti-apoptotic gene Bcl-2 and attenuated ethanol-
induced apoptosis by enhancing histone H3 acetylation at the Bcl-2 promoter in 
NCCs18.  
 Histone methylation and apoptosis 
           The other dominant histone modification is the methylation of lysine and 
arginine. The regulation of gene expression by histone methylation is correlated 
with specific histone methylation of lysine and arginine amino acids of histone N-
terminal tails. Histone methylation is well characterized at lysine residues 4, 9, 27, 
and 36 of histone H3 and at lysine 20 of histone H4. The effects of histone 
modifications on gene expression depend on the position of lysine residues that 
are methylated. For example, active genes are marked at their transcript start site 
(TSS) by H3K4me3, which facilitates transcriptional initiation50. Moreover, high 
levels of lysine trimethylation of H3 lysine 79 (H3K79me3) and trimethylation of H3 
lysine 36 (H3K36me3) at the promoter regions of genes also promotes gene 
expression72. On the other hand, the histone H3 lysine 27 trimethylation 
(H3K27me3)  and H3K9 methylation (H3K9me2 and H3K9me3) are linked to the 
repression of genes50, 72. These histone methylations were established by the 
writer KMTs and can be removed by the eraser KDMs. Both methylation and 
demethylation of histones at specific lysine residues are important 
posttranslational chromatin-associated modifications73. These modifications are 
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known to regulate nuclear function, including transcriptional regulation and 
epigenetic inheritance. Removal of repressive modifications (e.g. H3K27me3) 
helps to create transcriptional permissive chromatin while removing the permissive 
modifications (e.g., H3K4me3) contributes to the formation of repressive chromatin, 
suppressing gene expression72. Specifically, trimethylation at H3K4 (H3K4me3) 
plays a role in embryonic genome activation74. Dysfunction of H3K4me3 by a 
defect of KMTs results in the down-regulation of STAT3/BIRC5, which is 
responsible for the extremely high apoptotic rates of blastocysts75. In both mice 
and human stem cells, most of the H3K4me3-regulated genes are key factors in 
basic biological activities and in the maintenance of stem cell pluripotency76, 77. 
H3K4me3 markers can be removed by H3K4 histone demethylase KDM5A, which 
functions as a repressor by removing di- and tri-methyl groups. Loss of KDM5A 
has been shown to regulate cell proliferation, apoptosis and tumorigenesis in cell 
culture and in vivo models78, 79. It has been shown that KDM5A positively regulated 
metastasis-related genes, including TNC, and that therapeutically targeting 
KDM5A inhibited tumor progression78. A study has also shown that KDM5A 
knockout mice displayed a mild hematopoietic phenotype , which is correlated with 
depression of cytokine genes80. However, unlike histone acetylation, the role of 
KDMs in epigenetic regulation of apoptosis during embryonic development has not 
been studied so far.  
 Epigenetic cross-talk between DNA methylation and histone 
modifications 
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           Numerous associations exist between DNA methylation and histone 
modification. It has been established that DNA methylation at CpG island promoter 
can affect methylcytosine-binding proteins (MBD1, MBD2, MBD4 and MeCP1, 
MeCP2) to mediate transcriptional repression during gene silencing and 
heterochromatin formation81, 82. The MBD/MeCP1/2 proteins, in turn, recruit 
corepressor complexes containing HDACs 1 and 281. The growing evidence 
demonstrated that HDACs 1 and 2 are linked to the initiation and/ or maintenance 
of repression for DNA hypermethylated genes and that the simultaneous targeting 
of both DNA methylation and histone deacetylation leads to synergistic effects to 
inactive gene expression. In addition, the links between DNA methylation and 
histone methylation have also been demonstrated. Methylation of the histone H3 
lysine 9 residue serves to recruit the chromatin silencer HP1 and, in this way, leads 
to s gene repression83. The KMT has also been shown to interact with DNMT3a84 
and MBD185. Studies have also shown that KDM1A is commonly found in 
association with the CoREST transcriptional repressor complex, where it interacts 
with HDACs1 and 286, 87. HDAC inhibitor TSA induces hyperacetylation of histones 
and the level of H3K4me3, the substrate of KDM5A in the Trichomonas vaginalis88. 
Conversely, siRNA-mediated inhibition of KDM1A increases the abundance of 
H3K4ac, the substrate of HDAC89. These studies indicated that KDMs and HDACs 
were collaborated in establishing transcriptionally repressive chromatin and 
suggested that combined treatment targeting both KDM and HDAC may restore 
the silenced genes. In fact, studies by Huang et al. and Singh et al. have shown 
synergistic responses in cell proliferation in response to combined treatment with 
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HDAC and KDM inhibitors89, 90.  These studies suggest that combination therapy 
using the inhibitors of DNMT, HDAC, and KDM might be a rational approach for 
the prevention of FASD.  
 Epithelial-mesenchymal transition (EMT) and neural crest cells 
migration 
           NCC is a multipotent and migratory progenitor cell population that originates 
between the neural plate and non-neural ectoderm10. After induction at the border 
of the neural plate, NCCs leave their original location through a delamination 
process and migrate ventrally to differentiate into a diversity of neural and non-
neural cell types, including neuron, glia, craniofacial cartilage, bone and connect 
tissue91-94. EMT process is tightly correlated with the NCCs migration, which plays 
a pivotal role in craniofacial development. EMT is a process that orchestrated a 
change from an epithelial to mesenchyme phenotype, a process which also related 
to cell invasion and apoptotic resistance95, 96. EMT is essential for both normal 
development and cancer invasion and metastasis97-99. During embryonic 
development, NCCs undergo an EMT and then dissociate from the neural folds 
and differentiate to a diversity of cell types10, 91, 93. EMT also plays a vital role in 
promoting tumor proliferation, invasion, and metastasis, exerting an anti-apoptotic 
effect100, 101. Studies have also shown that EMT conferred resistance to UV-
induced apoptosis in three murine mammary epithelial cell lines102. Park et al. have 
also shown that α-mangostin can inhibit EMT and induce apoptosis in an 
osteosarcoma cell line103. However, the role of EMT in ethanol-induced apoptosis 
in NCCs and the pathogenesis of FASD remains to be defined. 
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           One of the well-known transcriptional factors that regulate EMT is Snail1104-
106. Snail1 promotes EMT primarily through the directly repressing E-cadherin, an 
EMT suppressing factor104, 107. Many studies have reported that various HDAC 
inhibitors promote EMT in prostate cancer, head and neck squamous cell 
carcinoma, and colon carcinoma108-110. A study has also shown that VPA, an 
HDAC inhibitor, induced EMT process via the up-regulation of Snail1108. The 
expression of Snail1 can be regulated by many mechanisms, including epigenetic 
regulation. A study by Dong Li et al. demonstrated that the H3K4me3 enrichment 
increased in the vicinity of the Snail1 transcriptional start site (TSS) in the process 
of TGF-β-induced EMT in prostate cancer cells111.  
 Sulforaphane is an inhibitor for both DNMTs and HDACs 
          Sulforaphane (SFN) is a vegetable-derived isothiocyanate that is abundant 
in cruciferous vegetables such as broccoli. Numerous studies have shown that 
SFN exhibits anti-cancer effects and prevents diabetic complications in 
experimental models112-114.  Studies on the mechanisms underlying the anticancer 
activities of SFN indicate that its effects on the tumor cell cycle, apoptosis, and 
angiogenesis are mediated by the modulation of the related signaling pathways 
and genes115. Our previous studies have shown that SFN exerts an anti-apoptotic 
effect through upregulating antioxidant gene Nrf-2 in NCCs17. More recently, SFN 
is drawing great attention because of its ability to inhibit HDACs and DNMTs, two 
key enzymes involved in histone deacetylation and DNA methylation, respectively, 
to cause epigenetic modification of genes in various types of cells, including the 
genes involved in EMT in cancer cells115-117. SFN was found to inhibit the LPS-
14 
 
induced HDAC6, HDAC10 and DNMT3a gene expression, conferring resistance 
to LPS-induced apoptosis in porcine monocyte-derived dendritic cells118. Our 
recent studies have also shown that SFN can prevent ethanol-induced apoptosis 
in NCCs by reversing ethanol-induced reduction of histone acetylation at the 
promoter of the anti-apoptotic gene, Bcl218.  
 Broccoli sprout extract (BSE) 
           Recently, broccoli sprout extract (BSE) has gained a lot of attention 
because it can specifically deliver a reproducible and standardized dose of 
glucoraphanin, a precursor of SFN. The majority of SFN is formed when 
glucoraphanin is hydrolyzed by the plant enzyme, myrosinase, upon plant tissue 
damage (e.g., chopping, chewing)119. As a precursor of SFN, glucoraphanin is 
available in commonly consumed cruciferous vegetables. BSE is considered to 
have a low toxicity, and its administration in humans is well tolerated120-122. Studies 
have shown that dietary consumption of cruciferous vegetables, like BSE, which 
contains SFN, may reduce the risk of several types of cancers, including prostate, 
breast, lung and colorectal cancer119, 123, 124. One of the mechanisms through which 
BSE acts as a cancer chemopreventive agent is its ability to inhibit HDAC activity. 
It has been reported that consumption of  BSE inhibited HDAC activity in peripheral 
blood mononuclear cells, accompanied by the induction of acetylation of histone 
H3 and H4 in human subjects125.  Moreover, the study by Dr. Hashimoto et al. has 
shown that dietary intake of SFN-rich BSE was capable of preventing PCP-induced 
cognitive deficits and oxidative stress in mice126. Furthermore, SFN-riched BSE 
significantly improved social interaction, abnormal behavior, and verbal 
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communication in young men with autism spectrum disorders120. Together, these 
results suggest that SFN-rich BSE could have potential therapeutic effects in 
patients with neurodevelopment problems. Thus, in the present study, I will 
investigate whether maternal dietary BSE can confer in vivo protection against 
ethanol-induced teratogenesis.  
 Statement of goal 
      FASD is a major development defect caused by maternal drinking alcohol 
during pregnancy. Growing evidence has shown that ethanol-induced excessive 
cell death in the specific cell population is one of the major mechanisms underlying 
the pathogenesis of FASD. However, there is a fundamental gap in understanding 
how ethanol leads to apoptotic cell death in vitro and in vivo. SFN is a chemical 
that is abundant in cruciferous vegetables, including broccoli, SFN is known to 
regulate gene expression through an epigenetic mechanism. The goal of this study 
is to elucidate the epigenetic mechanisms by which SFN epigenetically regulates 
the anti-apoptotic gene expression and prevents ethanol-induced apoptosis and 
teratogenesis, as well as to develop new therapeutic approaches for the prevention 
of FASD.  
 Specific aims  
 Aim1: To identify the anti-apoptotic genes that are epigenetically 
silenced by ethanol and de-repressed by SFN in ethanol-induced 
hNCCs. 
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           The objective of this aim is to identify the anti-apoptotic genes that are 
epigenetically regulated by SFN and ethanol through DNA methylation or histone 
modification. The sub-aims are 1) to identify the anti-apoptotic genes that are 
repressed by ethanol and de-repressed by SFN in hNCCs; 2) to identify the anti-
apoptotic genes that are hypermethylated by ethanol and de-methylated by SFN 
in hNCCs; and 3) to identify the anti-apoptotic genes with promoter-associated 
histone modifications induced by ethanol and SFN in hNCCs. 
 Aim2: To further explore the mechanism by which SFN epigenetically 
modulates the anti-apoptotic genes and apoptosis. 
           I expected to identify a group of anti-apoptotic genes that are epigenetically 
regulated by ethanol and SFN from Aim 1. The objective of this aim is to further 
explore the mechanism by which SFN epigenetically modulates the anti-apoptotic 
genes and apoptosis. The three sub-aims in this aim are 1) to determine the effects 
of ethanol and SFN on specific DNMT/HDAC/KDM in  hNCCs; 2) to analyze the 
changes of DNA methylation or histone modification at the promoter of anti-
apoptotic genes and the expression of selected anti-apoptotic genes in hNCCs 
treated with ethanol or/and  SFN; and 3) to determine whether SFN prevents 
hNCCs from ethanol-induced apoptosis by targeting specific DNMT/HDAC/KDM. 
 Aim 3: To explore the novel therapeutic approach for the intervention 
of ethanol-induced teratogenesis through maternal dietary 
administration of SFN-rich broccoli sprout. 
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           Alcohol-induced apoptosis plays an important role in the pathogenesis of 
FASD. Therefore, a strategy for the prevention of ethanol-induced apoptosis 
through epigenetic modification of the anti-apoptotic genes can be very promising. 
The sub-aims in this aim are 1) to determine whether maternal dietary BSE can 
epigenetically restore the anti-apoptotic genes in ethanol exposed mouse embryos; 
2) to determine whether maternal dietary BSE can prevent ethanol-induced 
apoptosis in mouse embryos; and 3) to determine whether dietary consumption of 
BSE can confer in vivo protection against ethanol-induced teratogenesis.
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CHAPTER II 
 
EXPERIMENTAL PROCEDURES 
 
 Cell culture and treatment 
 Mouse neural crest cells 
           Mouse neural crest cells (JoMa 1.3 cells) were cultured on culture dishes 
coated with 10 µg/mL fibronectin. NCCs were pretreated with or without 1 µM SFN 
(LST Laboratories, St. Paul, MN) for 24 hours, followed by concurrent exposure to 
1 µM SFN and 50 or 100 mM ethanol for an additional 24 hours. The stable ethanol 
levels were maintained by placing the cell culture dishes or plates in a plastic 
desiccator containing ethanol in distilled water. 
 Human neural crest cells 
           Human neural crest cells were differentiated from human embryonic stem 
cells (hESCs), which were purchased from WiCell® (Madison, WI, USA). hESCs 
were cultured in mTsSRTM1 (StemCell Technologies, Inc., Vancouver, Canada) on 
hESC-qualified MatrigelTM (BD Biosciences, San Jose, CA) coated plates. The 
differentiation procedures are as follows:  
           1) The hESCs were first adapted to Accutase® solution and dissociated into 
single-cell before they were differentiated to neural crest cells. Specifically, the    
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hESCs maintenance medium mTsSRTM1 were aspirated, and Accutase® cell 
dissociation reagent was added and incubated for 5-10 minutes at room 
temperature (RT). The colonies were gently collected once the colonies began to 
conform to round shape and to detach from the plate, and centrifuged the cells at 
room temperature for 4 min at 200 g. The cells were maintained at 37˚C in a 5% 
CO2 incubator and changed the medium with mTsSRTM every day.  
          2) When hESCs plates have reached 75-85% confluence, they are ready to 
be passaged and differentiated into hNCCs. Aspirated hESCs maintenance 
medium from culture dish and add Accutase® to detach the cells. Collected the 
cells in a 15 mL tube and centrifuged for 4 min at 200 g at room temperature. 
Aspirated the supernatant and resuspend the cells in a hNCCs differentiation 
medium (DMEM/F-12 Medium, 14.3 M L-Glutamine+β-mercaptoethanol, MEM 
Non-Essential Amino Acid, 10 µg/mL Fgf2, 10 µg/mL Heregulin β-1, 200 µg/mL 
Long® R3-IGF1, 10 mM CHIR 99021, 10 mM SB421542 and Penicillin and 
streptomycin). Upon reaching proper confluence (75%-85%), typically every 3-4 
days, the differentiating cells should be passed using Accutase® and then 
maintained in hNCCs differentiation medium. The hNCCs were validated by 
immunocytochemistry using the NCC marker HNK1 antibody. 
 Animals and treatments 
 Mice maintenance, time mating and BSE treatment 
          C57BL/6 mice were housed in a pathogen-free barrier facility accredited by 
the Association for Assessment and Accreditation of Laboratory Animal Care, and 
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all procedures used for this study were approved by the University of Louisville’s 
Institutional Animal Care and Use Committee. 
          The female mice were acclimated to a modified liquid diet (Bioserve Inc.) 
containing ethanol with 5% sucrose to increase palatability. As described 
previously (Parnell et al., 2016), the mice were given a liquid diet containing 2.4% 
(wt/vol) ethanol for 2 days, then the concentration of ethanol in the diet was 
increased to 4.8% for 14 days. After this acclimation period, the mice were taken 
off the liquid diet for an abstinence period for 4 days, during which they were 
maintained with the standard chow and water. The mice were then bred by placing 
1 or 2 females, with 1 male for a 2 hours period during the beginning of the dark 
cycle. The female mice were then examined for a copulation plug. The beginning 
of the breeding period in which a copulation plug was found was designated as the 
gestational day (GD) 0. SFN-rice broccoli sprout extract (BSE) was provided by Dr. 
Jeb Fahey in the Cullman Chemoprotection Center at The Johns Hopkins 
University. SFN content in this standardized, myrosinase-treated BSE is around 
216 µmol SFN/g powder. The amount of broccoli sprout extract to be incorporated 
into the liquid diet was calculated on the basis of the food intake and body weights 
of the animals, to give the SFN dosage of 75 mg/kg body weight/day. On GD7 and 
GD 8, the mice were assigned to 5 groups and placed back on the liquid diet 
containing: 4.8% ethanol (EtOH group), 4.8% ethanol plus BSE (EtOH+BSE 
group), BSE alone (BSE group), pair-fed control liquid diet (Pair-fed control group), 
and normal liquid diet (control group). Isocaloric amount of maltodextrin was added 
to BSE and control groups to control for the calories derived from the ethanol.  A 
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pair-fed control group was also included in this study to control for effects of the 
decreased diet intake observed in the EtOH group. This group of female mice was 
given volumes of the control liquid diet that were matched, based on milliliter diet 
per gram body weight, to those of the ethanol-exposed mice. During the ethanol 
exposure period, body weight and diet consumption were recorded every day. 
Pregnant mice were killed on GD 9.0, and embryos were collected for biochemical 
studies and the examination of apoptosis and dysmorphology. The other pregnant 
mice were returned to lab chow and water until GD 14 for the examination of the 
incidence and severity of ocular abnormalities. 
 Fish maintenance, mating and treatment 
          Zebrafish were purchased from Zebrafish International Resource Center 
(ZIRC; Eugene, OR) and raised and cared for by using the standard protocol127. 
All procedures used in this study were approved by the University of Louisville’s 
Institutional Animal Care and Use Committee. 
          Zebrafish were bred and maintained under standard conditions at 28.5˚C in 
a zebrafish housing system (Aquaneering; San Diego, CA). The setup was 
equilibrated with fish water (75 g NaHCO3, 18 g sea salt, 8.4 g CaSO4 per 1000 
mL). Fish embryos were obtained by placing males and females in a setup box 
containing a plastic partition plate. The eggs were spawned 2 hours after removing 
the partition. Viable embryos were collected and rinsed with fish water. Then the 
embryos were treated with 1% ethanol with or without 1 µM SFN during 3 – 24 
hours post-fertilization (hpf). For the KDM5A knockdown study in zebrafish 
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embryos, ~10 nL morpholino KDM5A was microinjected into the one-cell stage 
embryos. 
C. Molecular analyses  
 Nuclear extraction 
           Nuclear extracts were isolated using the EpiQuik Nuclear Extraction Kit 
(Epigentek, Brooklyn, NY), following the manufacturer’s protocol. Briefly, treated 
cells were collected and then washed with PBS, resuspended the cells with diluted 
NE1 (1: 10 with distilled water) and incubated on ice for 10 min, then centrifuged 
the preparation for 1 min at 12, 000 rpm, and discarded the supernatant, followed 
by adding 2 volumes of NE2 to the nuclear pellets. Incubated the extract on ice for 
15 min, and then sonicated for 3 x 10 seconds by using a Qsonica Q125 sonicator 
(QSonica, Newtown, CT) to increase the nuclear protein extraction. Centrifuged 
the suspension for 10 min at the maximum speed at 4˚C and transferred the 
supernatant into a new tube. The protein concentration was measured by BSA 
Assay Reagent (Pierce, Thermo Scientific). 
 Quantitative real-time PCR 
           For quantitative real-time PCR, total RNA was isolated from the control and 
treated NCCs using a QIAGEN RNeasy mini kit (QIAGEN, Valencia, CA) according 
to the manufacturer’s instruction. Total RNA was reverse transcribed using a 
QuantiTect Reverse Transcriptional Kit (QIAGEN, Valencia, CA) following the 
manufacturer’s instruction. Quantitative RT-PCR was performed on a Rotor-Gene 
6000 Real-time PCR system (Corbett LifeScience, Mannheim, Germany). The 
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following primer sets were used for this analysis: Snail1 (Mus musculus) forward: 
5’-GCCCTGCATCTGTAAGGTGT-3’, reverse: 3’-CCGGGCATTGACCTCATTCT-
5’; E-cadherin (Mus musculus) forward: 5’-CATCGCCTACACCATCGTCA-3’, 
reverse: 3’-CCGGGCATTGACCTCATTCT-5’; β-Actin (Mus musculus) forward: 5’-
CCATCCTGCGTCTGGACCTG-3’, reverse: 3’-GTAACAGTCCGCCTAGAAGC-5’.  
KDM5A (Mus musculus) forward: 5’-AAGTTGCCTGTACGGTTGCC-3’, reverse: 
3’-GGAAACTAGGTAAGTGTCCCTGT-5’. Bcl2 (Mus musculus) forward: 5’- 
TCTTTGAGTTCGGTGGGGTC -3’, reverse: 3’- AGTTCCACAAAGGCATCCCAG-
5’. AKT1 (Mus musculus) forward: 5’- AAGGACCCTACACAGAGGCT-3’, reverse: 
3’- TAGGAGAACTTGATCAGGCGG-5’. BIRC5 (Mus musculus) forward: 5’- 
CACCTTCAAGAACTGGCCCT-3’, reverse: 3’- ATCGGGTTGTCATCGGGTTC-5’. 
BIRC6 (Mus musculus) forward: 5’- CTGTGAGTTCCTTCGGGGTT-3’, reverse: 3’- 
CTACCTGGGCTGCTGAACTC -5’. NAIP (Mus musculus) forward: 5’- 
TTCCCCTTACAGCCACCTAAA-3’, reverse: 3’- AGAGGCCTTACTCAGCTCCA-
5’. MCL1 (Mus musculus) forward: 5’- TGCTCCGGAAACTGGACATTA-3’, reverse: 
3’- GTGTTTGGCCACAAAGGCAC-5’. XIAP (Mus musculus) forward: 5’- 
CTGGCCGGACTATGCTCATT-3’, reverse: 3’- CACGATCACAGGGTTCCCAA-5’. 
IGF1R (Mus musculus) forward: 5’- TCCGCAACGACTATCAGCAG-3’, reverse: 
3’- GAAGAGTTTCCAGCCACGGA-5’. Snail1(Danio rerio) forward: 5’- 
CAGCTTGCTACCTTCCCTTCA-3’, reverse: 3’- GAACGGACGCTCACCTGTAT-
5’. E-cadherin (Danio rerio) forward: 5’-CAAGGTGGTCCTGAGAGTTGC-3’, 
reverse: 3’-GAGCAGAAGAAGAGCAAGCAATAG-5’. KDM5A (Danio rerio) 
forward: 5’- ATGATGGAGGGAGACCTGCT-3’, reverse: 3’- 
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GGGCCCATCTTCAGCTTCTT-5’. AKT1 (Homo sapiens) forward: 5’-
CAGGATGTGGACCAACGTGA-3’, reverse: 3’-AAGGTGCGTTCGATGACAGT-5’. 
BCl2 (Homo sapiens) forward:5’- TGGCCTTCTTTGAGTTCGGT-3’, reverse: 3’- 
ACTTGTGGCCCAGATAGGCA-5’. BIRC5 (Homo sapiens) forward: 5’- 
AGGACCACCGCATCTCTACA-3’, reverse: 3’- TTTCCTTTGCATGGGGTCGT-5’. 
BIRC6 (Homo sapiens) forward: 5’- GGCTAACACCAATGGAGGCT-3’, reverse:3’- 
GGAACTCATTGCATCATCCCT-5’. IGF1R (Homo sapiens) forward: 5’- 
TCGACATCCGCAACGACTATC-3’, reverse: 3’- 
CCAGGGCGTAGTTGTAGAAGAG-5’. MCL1 (Homo sapiens) forward: 5’- 
GACTTTTGGCCACCGGC-3’, reverse: 3’- GAGAGTCACAATCCTGCCCC-5’. 
NAIP (Homo sapiens) forward: 5’-GCCTAGATGCAGTTCAGTTGG-3’, reverse: 3’- 
GGCACCAAAGAGGATTAGGCT-3’. XIAP (Homo sapiens) forward: 5’- 
GGTGAAGGAGATACCGTGCG-3’, reverse: 3’- GCATGTGTCTCAGATGGCCT-
5’. Nrf2 (Homo sapiens) forward: 5’- GAGACAGGTGAATTTCTCCCAA-3’, reverse: 
3’- AACGTAGCCGAAGAAACCTCA-5’. β-Actin (Homo sapiens) forward: 5’- 
AGAAGGATTCCTATGTGGGCG-3’, reverse: 3’- 
GGATAGCACAGCCTGGATAGCA-5’. The primers were synthesized by 
Integrated DNA Technologies, Inc. (IDT, Coralville, IA, USA). All assays were 
carried out in triplicate. Relative quantitative analysis was performed by comparing 
the threshold cycle number for target genes and a reference β-Actin mRNA. 
  Western blotting 
            Control and treated NCCs were washed twice with iced PBS and then lysed 
in cold RIPA lysis buffer with 1 mM PMSF and protease cocktail inhibitor. Whole-
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cell lysates were centrifuged at 12,000 x g for 10 min at 4˚C, and the supernatants 
were used for Western blot. The protein concentration in each sample was 
measured by using the BCA Protein Assay Reagent Kit (Pierce, Thermo Scientific, 
Waltham, MA). The protein levels of Histone H3, acetyl-Histone H3, Histone H3 
(tri methyl K4), cleaved caspase-3, E-cadherin, Vimentin, JARID1A, DNMT1, 
DNMT3A, DNMT3B, HDAC1, HDAC2, HDAC3 and β-Actin were analyzed with the 
following antibodies: anti-acetyl-Histone H3 rabbit pAb (06-799; Millipore, 
Temecula, CA). anti-Histone H3 rabbit pAb (06-755; Millipore, Temecula, CA), anti-
Histone H3 (tri methyl K4) rabbit pAb (ab8580, Abcam, Cambridge, MA), anti-
cleaved caspase-3 rabbit mAb (9661, Cell Signaling, Beverly, MA, USA), anti-E-
cadherin rabbit mAb (14472, Cell Signaling, Beverly, MA, USA), anti-vimentin 
rabbit mAb (5741, Cell Signaling, Beverly, MA, USA), anti-JARID1A rabbit mAb 
(3876, Cell Signaling, Beverly, MA, USA), anti-DNMT1 rabbit mAb (5032, Cell 
Signaling, Beverly, MA, USA), anti-DNMT3A rabbit mAb (32578, Cell Signaling, 
Beverly, MA, USA), anti-DNMT 3B rabbit mAb (57868, Cell Signaling, Beverly, MA, 
USA), anti-HDAC1 rabbit mAb (34589, Cell Signaling, Beverly, MA, USA), anti-
HDAC2 rabbit mAb (57156, Cell Signaling, Beverly, MA, USA), anti-HDAC3 rabbit 
mAb (85057, Cell Signaling, Beverly, MA, USA). anti-β–Actin mouse mAb (Santa 
Cruz, Santa Cruz, CA), respectively. Western blot was performed by standard 
protocols, and the densitometry of the blot band was analyzed by ImageJ software 
(National Institute of Health, USA). All Western blot analyses were performed in 
triplicate. 
  ChIP-qRT-PCR analysis 
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           ChIP assay was performed using a ChIP assay kit (Millipore, Temecula, CA) 
according to the manufacturer’s instruction. Briefly, NCCs from control and treated 
groups were collected and cross-linked with 1% formaldehyde for 10 min at 37˚C, 
and subjected to digest with SDS lysis buffer, then sonicated to shear DNA to the 
length between 200 and 1000 bp using a Qsonica Q125 sonicator (QSonica, 
Newtown, CT). The chromatin samples were diluted with ChIP dilution buffer and 
immunoprecipitated using 1µg of H3K4me3 rabbit pAb antibody (Abcam, 
Cambridge, MA) and mouse monoclonal (Ig)G (Santa Cruz, Santa Cruz, CA), used 
as a negative control. Protein A agarose beads were added for precipitation and 
then were washed and eluted, and DNA was purified for real-time PCR assay. For 
DNA purification, the DNA was first treated with proteinase K to remove protein 
and reverse the cross-links and was then purified by ChIP DNA clean & 
Concentrator Kits (ZYMO Research, Irvine, CA). Quantitative real-time PCR was 
performed on bound and input DNAs with the following primer pairs: Snail1 (Mus 
musculus) P1 forward: 5’- GGCATCCCTGGGTAGTGTTTT-3’, reverse: 3’-
GCATGTTGGCCAGAGCGAC-5’; P2 forward: 5’- 
GAGCCCAAGCGGAATCTCAG-3’, reverse: 3’-GCATGTTGGCCAGAGCGAC-5’, 
P3 forward: 5’- CACCTGCTCCGGTCTCAG-3’, reverse: 3’-
GCATGTTGGCCAGAGCGAC-5’, P4 forward: 5’- CAACAGTACGGTCACGCCC-
3’, reverse: 3’-GCATGTTGGCCAGAGCGAC-5’, P5 forward: 5’- 
GCCTTGACAAAGGGGCGT-3’, reverse: 3’- GTCAAAGACACCCTCGGTGG-5’. 
MCL1 (Homo sapiens) P1 forward: 5’- GAGAAGGCCCGAGGTGCTCATGGA-3’, 
reverse: 3’- TCCTACGGGGTGGCGCCAGCGA-5’; P2 forward: 5’- 
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GTTACGTAACCGGCACTCAGAGC-3’, reverse: 3’- 
TCCTACGGGGTGGCGCCAGCGA-5’; P3 forward: 5’- 
CGGGCAGCTGGTAGGTGCCGT-3’, reverse: 3’- 
TCCTACGGGGTGGCGCCAGCGA-5’. IGF1R (Homo sapiens) P1 forward: 5’- 
GGAGATGGGGGCGGCGCCTCGCA-3’, reverse: 3’- 
TCCTCGGGTTTTTTCCCTTTTT-5’; P2 forward: 5’- 
CCGGTTTTTTGCGCGCGCCGGCCT-3’, reverse: 3’- 
TCCTCGGGTTTTTTCCCTTTTT-5’; P3 forward: 5’- 
TGCGAGCGGGCGCGTGTGCGCGGG-3’, reverse: 3’- 
TCCTCGGGTTTTTTCCCTTTTT-5’. BIRC6 (Homo sapiens) P1 forward: 5’- 
GGCCACGGCCGAACAGCTGCACC-3’, reverse: 3’- 
CCGGCGGGTGGAGCATGCGCG-5’; P2 forward: 5’- 
GGGCGTACCGGACAGGTCGCAAG-3’, reverse: 3’- 
CCGGCGGGTGGAGCATGCGCG-5’; P3 forward: 5’- 
TGCCCCCGCGAGGAGCGGGGCGG-3’, reverse: 3’- 
CCGGCGGGTGGAGCATGCGCG-5’. AKT1 (Homo sapiens) P1 forward: 5’- 
GGCCGGGCTCCGTTAGCGGCCCAG-3’, reverse: 3’- 
TGCCCAGCGCTCGGTGCTCGGC-5’; P2 forward: 5’- 
CGAGCGCGCTCCGCCCTCGCCGCC-3’, reverse: 3’- 
TGCCCAGCGCTCGGTGCTCGGC-5’; P3 forward: 5’- 
CGGCTCCGGGCGCGGGGCGGGCGC-3’, reverse: 3’- 
TGCCCAGCGCTCGGTGCTCGGC-5’. BIRC5 (Homo sapiens) P1 forward: 5’- 
AGGCCTCTCAAAGTGTTGGGATTA-3’, reverse: 3’- 
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GCGATTCAAATCTGGCGGTT-5’; P2 forward: 5’- 
GGGGGCGCTAGGTGTGGGCAGGGA-3’, reverse: 3’- 
GCGATTCAAATCTGGCGGTT-5’; P3 forward: 5’- 
CGCGGCGGGAGGACTACAACTCCC-3’, reverse: 3’- 
GCGATTCAAATCTGGCGGTT-5’. NAIP (Homo sapiens) P1 forward: 5’- 
GCATGCTGTTGTGATTTTCTAGGA-3’, reverse: 3’- 
AGATCTCTCCCTTGTGAGGGGCTT-5’; P2 forward: 5’- 
TGGAAAGCACATGGCATGTCAAGG-3’, reverse: 3’- 
AGATCTCTCCCTTGTGAGGGGCTT-5’; P3 forward: 5’- 
GATTAGGGTGGGGCGCCCAACCTT-3’, reverse: 3’- 
AGATCTCTCCCTTGTGAGGGGCTT-5’. XIAP (Homo sapiens) P1 forward: 5’- 
TGACCTCCCGGCCGGGGGTGGGAG-3’, reverse: 3’- 
CCCGCGGCGATCGGCTCGGTCCA-5’; P2 forward: 5’- 
CGCCCGGTGTCTCTTTGAGGCCCT-3’, reverse: 3’- 
CCCGCGGCGATCGGCTCGGTCCA-5’; P3 forward: 5’- 
GGGCCGGCCGGTAGAGGCGCGTGA-3’, reverse: 3’- 
CCCGCGGCGATCGGCTCGGTCCA-5’. 
 Methylated Specific PCR (MSP) 
           The methylation status of CpG island of all samples was determined by 
MSP. CpG islands were predicted by Methyl Primer Express software (Life 
Technologies, Grand Island, NY) using the following parameters: -CGI size 300-
2000 bp, C+Gs/ total base > 50%, CpG observed/CpG expected > 60%. Genomic 
DNA was extracted from control and treated NCCs by using DNeasy® Blood & 
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Tissue Kit (QIAGEN, Valencia, CA) according to the manufacturer’s instruction. 1 
µg of genomic DNA was processed with the EpiTect® Bisulfite Kit (QIAGEN, 
Valencia, CA), during which the methylated DNA is protected and unmethylated 
cytosine is converted to uracil. The modified DNA was used as a template for PCR 
using primers specific for the methylated (M pair) and unmethylated sequences (U 
pair) (Table 1) and the methylated DNA and unmethylated DNA were amplified. 
The PCR products were then separated on a 2% agarose gel. When the CpG sites 
in the region analyzed by MSP were methylated, the methylated bands (M) 
presented. The unmethylated (U) bands presented when the sites were 
unmethylated. Both M and U bands were presented when the sites were partially 
methylated.  
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Table1: Primer sets of ten anti-apoptotic genes used for MSP. 
 siRNA transfection 
            KDM5A siRNA (SMART pool: ON-TARGET plus mouse KDM5A), HDAC2 
(SMART pool: ON-TARGET plus human HDAC2), and DNMT3A (SMART pool: 
ON-TARGET plus human DNMT3A) were purchased from Dharmacon (Lafayette, 
Gene  Methylation Specific Primers Unmethylation specific primers Product 
size(bp) 
AKT1 Forward 5'-AGTATCGAGCGTTGGGTATC 5'-GAGTATTGAGTGTTGGGTATT 167 
Reverse 3'-GAACGCGAACCTAACCGA 3’-CAAACACAAACCTAACCAA 167 
BCL2 
CpG 1 
Forward 5'-TTAAAATTGTTTGTTTGCGC 5'-ACCGTCCTAACGCTAAAATAAA 155 
Reverse 3' 
AATTTAAAATTGTTTGTTTGTGT  
5'- 
CCCACCATCCTAACACTAAAATAAA  
155 
BCL2 
CpG2 
Forward 5'-
AGTTGTCGTAGAGGGGTTAC 
5'-ATAAGTTGTTGTAGAGGGGTTAT 156 
Reverse 3'-TCTACAACGACGAAATCCT 3'-TCTACAACAACAAAATCCTAAC  156 
BIRC5 Forward 5'-CGCGTTTTTTGAAAGTAGTC 5’- GTATGTGTTTTTTGAAAGTAGTT 227 
Reverse 3'-TCTAACGATTAATAACGCGC 3'-AATCTAACAATTAATAACACACC 227 
BIRC6 Forward 5'-GTATGTATTGCGACGTCGAC 5'- GTTGTATGTATTGTGATGTTGAT  119 
Reverse 3'-TATAACCCCCGAAATACCG 3'-CAATATAACCCCCAAAATACCA 119 
IGF1R 
CpG 1 
Forward 5'-GGTTTTACGGTCGTAACGTC 5'-GGGTTTTATGGTTGTAATGTT 126 
Reverse 3'-CGTACTAAAAAACCCGAACG 3'-ACATACTAAAAAACCCAAACA 126 
IGF1R 
CpG 2 
Forward 5'-AGTTTTGGGTCGTTGTTGTC 5'-GAGTTTTGGGTTGTTGTTGTT 100 
Reverse 3'-ACAATACTCCGAAAACGACG 3'-AACAATACTCCAAAAACAACA 100 
MCL1 Forward 5'-GGTACGAGTCGGAGTTTTTC 5'-GGGTATGAGTTGGAGTTTTTT 192 
Reverse 3'-CGATAACCTACTCCCGAAAA 3'-CCAATAACCTACTCCCAAAAA 192 
NAIP Forward 5'-AGGTTGGAGTATCGTGGC 5'-TTTAGGTTGGAGTATTGTGGT 118 
Reverse 3'-GAACGTAATAACGAACGCCT 3’- ACCAAACATAATAACAAACACCT 118 
XIAP Forward 5'-
GGCGGAGGTTGTAGTGAGTC 
5'- 
GGAGGTGGAGGTTGTAGTGAGTT 
114 
Reverse 3'-ATAAACATAAACCACCGCGC 3'- 
TATAAACATAAACCACCACACCC 
114 
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CO). Each 5 nmol stock siRNA was reconstituted into 10 µM aliquots. Scramble 
control siRNA (siCon) was purchased from Integrated DNA Technologies 
(Coralville, IA).  For siRNA transfection, NCCs were seeded at 125,000 cells/per 
well in 12-well plates and transfected with siRNA or siCon in a final concentration 
of 25 nM by using lipofectamineTM2000 (Thermo Fisher, Waltham, MA), according 
to manufacturer’s instruction. 24 hours post-transfection, the cells were harvested 
at 24 hours after transfection for experiments. 
 Analysis of apoptosis 
           Apoptosis in NCCs was determined by the analysis of cleavage of caspase-
3 and the flow cytometry analysis of Annexin V staining. Caspase-3 cleavage was 
determined by Western blot, as described previously17. The number of apoptotic 
cells was determined by flow cytometry using a FITC Annexin V apoptosis 
detection kit (BD Bioscience, Franklin Lakes, NJ, USA), following the 
manufacturer’s instruction. Briefly, control and treated NCCs were collected, 
washed twice with PBS, resuspended in binding buffer, and then incubated with 
Annexin V and PI for 15 min. The apoptotic cells were detected using a 
FACSCalibur flow cytometer (BD Bioscience, Franklin Lakes, NJ, USA.) 
             The whole-mount TUNEL staining of embryos for detection and 
quantification of the apoptotic cells in zebrafish was performed using the TMR red 
in situ Detection Kit (Millipore, Temecula, CA). The embryos were fixed overnight 
in 4% paraformaldehyde in PBS at 4˚C. Samples were dehydrated with 100% 
methanol overnight, then rehydrated in successive dilutions of methanol (100%, 
75%, 50%, 25%, 0%) in PBS. The embryos were then permeabilized with 
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proteinase K (20 µg/mL in PBST) at room temperature for 10 min., followed by pro-
fixation in 4% PFA-PBS at room temperature for 20 min. The samples were then 
washed five times with PBST for 5 min each and incubated in 50 µL of TUNEL 
reaction mixture (5 µL of enzyme solution+ 45 µL label solution) in the dark at 37˚C 
for 2 hours. The reaction was stopped by washing the samples five times for 5 min 
each in PBST. Following the staining, embryos were visualized in the green 
channel of a fluorescent microscope (SZX16, Olympus, USA). 
 Statistical analysis 
           Statistical analyses were performed using GraphPad Prism software 
(GraphPad Software, San Diego, CA, USA). All data were expressed as mean ± 
SEM of at least three independent experiments. Comparisons between groups 
were analyzed by one-way ANOVA. Multiple comparison post-tests between 
groups were conducted using Bonferroni’s test. Differences between groups were 
considered significant at p < 0.05. 
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CHAPTER III 
 
SULFORAPHANE PROTECTS AGAINST ETHANOL-INDUCED APOPTOSIS IN 
HUMAN NEURAL CREST CELLS THROUGH DIMINISHING ETHANOL-
INDUCED HYPERMETHYLATION AT THE PROMOTERS OF THE ANTI-
APOPTOTIC GENES 
 Introduction 
      Prenatal alcohol exposure can cause a spectrum of physical abnormalities and 
mental dysfunctions in children, which are defined as FASD128, 129. Previous 
studies by Kotch and Sulik, as well as Dunty et al., have revealed that acute 
exposure to ethanol during gastrulation resulted in excessive cell death in neural 
crest cells (NCCs)14, 130. Using a chick-specific antibody to NCCs, Cart Wright and 
Smith confirmed that the regions of ethanol-induced apoptosis are premigratory 
cranial neural crest131. Studies from our laboratory have also shown that ethanol 
increased apoptosis in NCCs and that ethanol-induced apoptosis in NCCs 
contributes heavily to ethanol-induced malformations132, 133. However, the 
molecular mechanisms underlying the apoptosis that result from alcohol exposure 
are poorly understood. It is well-known that ethanol can induce modifications in 
DNA22-24 and histones25, 27-29, and such changes may mediate some detrimental 
effects of prenatal alcohol exposure and contribute to the abnormalities associated 
with FASD. An earlier study by Garro has shown that the fetal DNA was  
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hypermethylated after ethanol exposure during embryonic development30. 
Hypermethylation in the promoter regions of genes is associated with gene 
repression134. DNA hypermethylation is associated with the repression of many 
genes involved in various cellular functions, including DNA repair, cell adhesion, 
and apoptosis40, 135. DNA methylation has been shown to be associated with the 
repression of the apoptotic genes in cancer cells, which are known to avoid 
apoptosis39, 136, 137. Hypermethylation in the Casp 8 promoter was correlated with 
a low Casp 8 expression, conferring apoptosis resistance in different cancer cell 
lines, such as pediatric cancer138, lung carcinomas139 and breast cancers140. In 
contrast, hypermethylation at the promoters of the anti-apoptotic genes, including 
Bcl2 is associated with the down-regulation of Bcl2 gene expression and 
apoptosis141. These studies suggest that epigenetic regulation of apoptosis-related 
genes by modulating DNA methylation may contribute to the ethanol-induced 
apoptosis and the pathogenesis of FASD. 
       DNA methylation occurs on the cytosine residue of CpG dinucleotides through 
the transfer of 5-methylcytosine from the methyl donor S-adenosylmethionine 
(SAM) to the CpG. The reaction is catalyzed by a family of enzymes called DNA 
methyltransferases (DNMT), including DNMT1, DNMT3a and DNMT3b142. DNMT1 
is responsible for the maintenance of established patterns of DNA methylation, 
while DNMT3a and DNMT3b mediate the establishment of new or de novo DNA 
methylation patterns143, 144. Alteration of DNA methylation by DNMT may trigger 
hypermethylation or hypomethylation of gene promoters and consequently result 
in activating or inhibiting gene expression, which can be reversed by DNMT 
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inhibitor. Evidence from literature indicates that aberrant methylation of anti-
apoptotic genes by DNMT inhibitor may be involved in apoptosis resistance39, 46. 
Studies have shown that loss of methylation induced by DNMT inhibitor at the 
promoters of the IAP gene related to apoptosis resistance39. These results 
indicated that DNMTi may prevent apoptosis by regulating DNA methylation at the 
promoters of apoptosis-related genes. 
       Sulforaphane (SFN) is a vegetable-derived isothiocyanate that is abundant in 
cruciferous vegetables such as broccoli. Our previous studies have shown that 
SFN prevented ethanol-induced apoptosis through upregulating the anti-oxidant 
gene Nrf2 in NCCs17. In addition to acting as Nrf2 inducer, SFN has been found to 
regulate gene expression by inhibiting the activity of DNMTs, the enzymes involved 
in DNA methylation145. SFN was also found to inhibit LPS-induced DNMT3a gene 
expression, conferring resistance to LPS-induced apoptosis in porcine monocyte-
derived dendritic cells146.  
       In the present study, I tested the hypothesis that SFN can reverse ethanol-
induced apoptosis through epigenetic upregulation of the anti-apoptotic genes. I 
observed that eight anti-apoptotic genes (AKT1, Bcl2, BIRC5, BIRC6, IGF1R, 
MCL1, NAIP and XIAP) are repressed by ethanol and de-repressed by SFN in 
hNCCs. I also found that SFN can inhibit the enzymatic activity of DNMT in ethanol 
exposed hNCCs. SFN also diminished ethanol-induced upregulation of DNMT3a. 
Among eight anti-apoptotic genes, Bcl2, XIAP, BIRC5, BIRC6, and XIAP were 
hypermethylated by ethanol, which can be prevented by SFN treatment. 
Knockdown of DNMT3a significantly reversed ethanol-induced inhibition of NAIP 
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and XIAP expression and enhanced SFN’s effects on the mRNA and protein 
expression of NAIP and XIAP in hNCCs. I also found that SFN can prevent ethanol-
induced apoptosis by diminishing ethanol-induced upregulation of DNMT3a in 
hNCCs. These results demonstrate that SFN can prevent the ethanol-induced 
apoptosis by diminishing the ethanol-induced hypermethylation at the promoters 
of the anti-apoptotic genes in hNCC. 
 Experimental procedures 
  Cell treatment 
            hNCCs or NCCs were pretreated with or without 1µM SFN for 24 hours, 
followed by concurrent exposure to 1µM SFN and 50 mM ethanol for an additional 
24 hours.  Cell culture dishes were placed in a plastic desiccator containing 50 mM 
ethanol in distilled water to maintain the stable ethanol levels 
 MTS cell viability assay 
           Cells were seeded in a 96-well microtiter plate in a final volume of 200 
µL/well. For determining the dose-response effects of ethanol on cell viability, 
NCCs were treated with or without 25, 50, 100 mM ethanol for 24 hours. For 
determining the dose-response of SFN on ethanol-induced changes in cell viability, 
NCCs were treated with 0.5, 1, 2, 4 µM SFN for 24 hours, followed by 24 hours of 
concurrent exposure to SFN and 50 mM ethanol. After treatment, 20 µL /well MTS 
Reagent (Promega, Madison, WI) was added into each well and incubated for 1-4 
hours at 37 ºC in standard culture conditions. The quantity of the formazan product 
was measured at 490 nm using a plate reader. 
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  Western blot 
           The protein expression levels of DNMT1, DNMT3a, DNMT3b, cleaved 
caspase-3, NAIP and XIAP were determined by Western blot, as described in 
Chapter II, C.  
 Expression profiling of apoptosis-related genes using human 
apoptosis PCR array 
           The human RT2 Profiler PCR array was purchased from Qiagen (Valencia, 
CA). RNAs were isolated from control and treated cells, then cDNA was 
synthesized as described in Chapter II, Section C. 2. The PCR mixture 
components were prepared by adding the 2X RT2 SYBR Green Mastermix, cDNA 
synthesis reaction and RNase-free water and mixing well. The PCR mixture 
components were dispensed into the RT2 Profiler PCR array and, then proceed the 
plate to the RT-PCR machine. 
 Quantitative real-time PCR 
           mRNA expression of AKT1, BCl2, BIRC5, BIRC6, IGF1R, MCL1, NAIP, 
XIAP and β-actin were measured by quantitative real-time RT-PCR, as described 
in Chapter II, Section C. 2. 
 Analysis of DNMT activity 
           hNCCs from the control and treated groups were harvested, and nuclear 
extracts were isolated by using the EpiQuik Nuclear Extraction Kit (Epigentek) 
according to the manufacturer’s protocol. The protein concentrations of nuclear 
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extraction were measured using the BCA protein assay kit (Thermo Scientific). 20 
µg of nuclear extracts were used to determine the DNMT enzymatic activity, and 
the absorbance was read on a microplate reader at 450 nm. The DNMT activity 
was calculated using the following formula: 
DNMT activity (OD/h/mg) = (sample OD-Blank OD)/ (µg protein amount x hour) 
x1000 
 Statistical analysis 
           Statistical analysis was performed as described in Chapter II, Section D. 
 Results 
 Differentiation of hNCCs from hESCs.            
           hNCCs were differentiated from hESCs using the protocol described in 
Chapter II, section A. hNCCs were validated by the immunocytochemistry using 
the hNCC marker HNK1. The result of immunocytochemistry indicated that all 
hNCCs are positive for the hNCC marker HNK1 (Figure 3.1).  
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Figure 3. 1. Differentiation of hNCCs from hESCs. Immunocytochemistry analysis 
shows that hNCCs are positive for the NCC marker HNK1. 
  
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
 Ethanol treatment significantly increased apoptosis in hNCCs. 
           To determine whether ethanol exposure can decrease cell viability and 
increase apoptosis in hNCCs, hNCCs were exposed to 25, 50 or 100 mM ethanol 
for 24 hours. The cell viability was analyzed using the MTS assay. As shown in 
Figure 3.2A, 50 or 100 mM ethanol significantly reduced cell viability in hNCCs. 
Ethanol exposure also resulted in a dose-dependent manner, as indicated by the 
significant increase in caspase activation (Figure 3.2B).  
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Figure 3. 2. Ethanol exposure significantly reduced cell viability and increased 
apoptosis in hNCCs. hNCCs were exposed to 25, 50 or 100 mM ethanol for 24 h. 
Cell viability was determined by using the MTS assay (A). Apoptosis was analyzed 
by analysis of cleaved caspase-3 by western blotting (B). Data are expressed as 
a percentage of control (A) or fold change over control and represent the mean ± 
SEM of three separated experiments. *p<0.05, **p<0.01. 
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 SFN treatment prevented ethanol-induced apoptosis in hNCCs. 
           To determine whether SFN can reduce ethanol-induced reduction in cell 
viability in hNCCs, the cells were treated with ethanol or/and SFN at different 
concentrations for 24 hours. As shown in Figure 3.3A, SFN at 1 µM significantly 
diminished the reduction of cell viability in hNCCs exposed to 50 mM ethanol. 
Treatment with SFN also significantly reduced caspase-3 activation in hNCCs 
exposed to ethanol (Figure 3.3B). 
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Figure 3. 3. SFN prevented the ethanol-induced reduction of cell viability and 
apoptosis in hNCCs. (A) hNCCs were treated with 50 mM ethanol alone or co-
treated with SFN at the indicated concentration for 24 hours. Cell viability was 
determined by MTS assay. (B) hNCCs were exposed to 1 µM SFN for 24 h, 
followed by concurrent exposure to 1 µM SFN and 50 mM ethanol for 24 h. 
Apoptosis was determined by the analysis of caspase-3 cleavage using western 
blotting. Data are expressed as a percentage of control (A) or fold change over 
control (B) and represent the mean ± SEM of three separated experiments. 
*p<0.05, **p<0.01. 
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 Identification of anti-apoptotic genes that are repressed by ethanol 
and that their repression by ethanol can be prevented by SFN in 
hNCCs.  
           To identify the anti-apoptotic genes that were repressed by ethanol and de-
repressed by SFN in hNCCs, the RT2 human apoptosis array was used to profile 
the expression of apoptosis-related genes. The gene expression in hNCCs was 
depicted by the heat map with upregulation in red and downregulation in green 
(Figure 3.4A). The quantification of the heatmap was shown in Figure 3.4B. We 
have identified eight anti-apoptotic genes that were down-regulated by ethanol and 
that their down-regulation can be prevented by SFN, including AKT1, BCL2, BIRC5, 
BIRC6, IGF1R, MCL1, NAIP and XIAP. The results from human apoptosis array 
were validated by quantitative RT-PCR (Figure 3.4C).   
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Figure 3. 4. Identification of the anti-apoptotic genes that are repressed by ethanol 
and de-repressed by SFN. hNCCs were pre-treated with 1µM SFN for 24 hours 
and then co-treated with 1µM SFN and 50 mM ethanol for another 24 hours. The 
RT2 apoptosis array was used to profile the apoptosis-related genes expression in 
control and treated hNCCs, and the mRNA expression of 84 apoptosis-related 
genes was depicted by the heat map (A). Eight anti-apoptotic genes were identified 
from apoptosis array analysis (B). The mRNA expression of the selected anti-
apoptotic genes was validated using RT-PCR (C). The data were expressed as 
fold change over control and represent the mean ± SEM of three separated 
experiments. *p < 0.05. 
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 SFN diminished ethanol-induced increase in DNMT activity and up-
regulation of DNMT3a in hNCCs. 
           To determine the effects of ethanol and SFN on the activity of DNMT, 
hNCCs were pretreated with SFN for 24 hours, then co-treated with SFN and 
ethanol for another 24 hours. As shown in Figure 3.5A, treatment with SFN 
significantly reduced the ethanol-induced increase in the activity of DNMT in 
hNCCs. Three enzymatically active DNMTs, includingDNMT1, DNMT3a and 
DNMT3b, were involved in DNA methylation in eukaryotic cells38, 147. We thus 
examined the protein expression of DNMT1, DNMT3a and DNMT3b by Western 
blot in hNCCs. As shown in Figure 3.5B, while ethanol exposure did not 
significantly change the protein expression of DNMT1 and DNMT3b, ethanol 
exposure significantly increased the expression of DNMT3a in hNCCs. Co-
treatment with SFN and ethanol reduced ethanol-induced increase in DNMT3a 
expression. This result suggested that DNMT3a may be the primary 
methyltransferase responsible for ethanol-induced hypermethylation at the 
promoters of anti-apoptotic genes in hNCCs. 
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Figure 3. 5. Co-treatment with SFN and ethanol reduced DNMT activity and 
DNMT3a expression in ethanol exposed hNCCs. hNCCs were treated with 1 µM 
SFN for 24 hours, then co-treated with 1 µM SFN and 50 mM ethanol for an 
additional 24 hours. (A) Treatment SFN significantly reduced the ethanol-induced 
increase in the activity of DNMT in hNCCs (B) Co-treatment with SFN and ethanol 
significantly decreased the ethanol-induced increase in DNMT3a protein 
expression in hNCCs. Data are expressed as fold change over control and 
represent the mean ± SEM of three separated experiments. *p<0.05. 
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 SFN diminished the ethanol-induced hypermethylation at the 
promoters of the selected anti-apoptotic genes in hNCCs.  
           To determine whether ethanol-induced up-regulation of DNMT3a and 
increase in DNMT activity can result in hypermethylation at the promoters of the 
selected anti-apoptotic genes and whether SFN that can prevent ethanol-induced 
up-regulation of DNMT3a and increase in DNMT activity can diminish ethanol-
induced hypermethylation at the promoters of anti-apoptotic genes, the 
methylation of CpG islands at the promoters of the identified anti-apoptotic genes 
in human NCCs was analyzed by using methylation-specific PCR (MSP).  
Exposure to ethanol resulted in a significant increase in the methylation level at 
the promoters of Bcl2, XIAP, BIRC5, BIRC6 and NIAP. Co-treatment with SFN 
significantly diminished ethanol-induced hypermethylation at the promoters of 
these anti-apoptotic genes in human NCCs (Figure 3.6). These results 
demonstrated that ethanol exposure can induce hypermethylation at the promoters 
of the selected anti-apoptotic genes in hNCCs, which can be prevented by co-
treatment with SFN. 
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Figure 3. 6. SFN significantly diminished the ethanol-induced hypermethylation at 
the promoters of Bcl2, XIAP, BIRC5, BIRC6 and NAIP in hNCCs. hNCCs were 
pre-treated with 1 µM SFN for 24 hours and then continue to be exposed in medium 
containing SFN, ethanol, or in combination for 24 hours. (A) Schematic illustration 
of the CpG sites and CpG island in the promoter of the anti-apoptotic gene. (B) 
DNA methylation status at the CpG island of the selected anti-apoptotic genes was 
determined by using MSP. Data are expressed as fold change over control and 
represent the mean ± SEM of three separated experiments. *p < 0.05. M: 
methylated DNA, U: unmethylated DNA. 
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 Knockdown of DNMT3a and SFN treatment significantly diminished 
ethanol-induced down-regulation of NAIP and XIAP in hNCCs 
           To further confirm that DNMT3a is responsible for the ethanol-induced 
hypermethylation at the promoters of anti-apoptotic genes and subsequent down-
regulation of these genes, DNMT3a was knocked down by siRNA in hNCCs before 
treatment with ethanol and SFN. We found that ethanol exposure significantly 
decreased mRNA expression of NAIP and XIAP. Protein expression of NAIP and 
XIAP was also decreased in ethanol-exposed hNCCs. The knockdown of DNMT3a 
or treatment with SFN significantly diminished ethanol-induced decreases in the 
mRNA and protein expression of NAIP and XIAP. In addition, knockdown of 
DNMT3a enhanced the effects of SFN on the mRNA and protein expression of 
NAIP and XIAP (Figure 3.7A, B). These results indicated that either knockdown of 
DNMT3a or inhibition of DNMT activity by SFN can diminish ethanol-induced 
repression of anti-apoptotic genes in hNCCs.   
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Figure 3. 7. Knockdown of DNMT3a and SFN treatment significantly diminished 
ethanol-induced down-regulation of NAIP and XIAP in hNCCs. hNCCs transfected 
with control-siRNA or DNMT3A-siRNA were treated with 1µM SFN or 50 mM 
ethanol or co-treated with ethanol and SFN for further 24 hours. (A) The mRNA 
expression of NAIP and XIAP was determined by quantitative RT-PCR. (B) The 
protein expression of NAIP and XIAP was determined by western blotting. Data 
are expressed as fold change over control and represent the mean ± SEM of three 
separated experiments. *p < 0.05, **p<0.01.  
 
 
 
 
53 
 
 Knockdown of DNMT3a and SFN treatment prevented ethanol-induced 
apoptosis in hNCCs. 
           To determine whether ethanol-induced up-regulation of DNMT3a and 
subsequent hypermethylation at the promoters of the selected anti-apoptotic 
genes and repression of these genes contribute to ethanol-induced apoptosis and 
whether SFN can prevent ethanol-induced apoptosis by diminishing ethanol-
induced up-regulation of DNMT3a, DNMT3a was knocked down by siRNA in 
hNCCs. Apoptosis was determined by the analysis of caspase-3 activation using 
western blot. I found that ethanol exposure significantly increased apoptosis in 
hNCCs. The knockdown of DNMT3a by siRNA or down-regulation of DNMT3a by 
SFN significantly diminished ethanol-induced apoptosis in hNCCs (Figure 3.8). 
These results demonstrate that ethanol-induced up-regulation of DNMT3a 
contributes to ethanol-induced apoptosis and that SFN can prevent ethanol-
induced apoptosis in hNCCs by diminishing ethanol-induced up-regulation of 
DNMT3a.    
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Figure 3. 8. Knockdown of DNMT3a and SFN treatment prevented ethanol-
induced apoptosis in hNCCs. hNCCs transfected with siRNA-DNMT3a or siRNA-
control were treated with1 µM SFN or 50 mM ethanol or co-treat with SFN and 
ethanol for 24 hours. The protein expression of DNMT3a and cleaved caspase-3 
were determined by western blotting. Data are expressed as fold change over 
control and represent the mean ± SEM of three separated experiments. *p < 0.05, 
**p<0.01, ***p<0.001. 
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D.  Discussion 
     Ethanol-induced apoptosis in hNCCs is one of the major mechanisms 
underlying the pathogenesis of FASD. Studies have shown that epigenetic 
modifications contribute to the harmful consequences of alcohol abuse during 
pregnancy in the developing fetus35. Epigenetic modifications, such as altered 
DNA methylation and histone modifications, are thought to influence apoptosis-
related genes in response to ethanol exposure. Recent studies in our laboratory 
have demonstrated that ethanol exposure significantly increased apoptosis 
through decreasing histone acetylation on the promoter of the anti-apoptotic gene, 
Bcl218. However, the role of DNA methylation in the ethanol-induced apoptosis has 
not been well elucidated. In this study, I determined whether ethanol exposure can 
increase apoptosis through epigenetically repressing the anti-apoptotic genes and 
whether SFN, a well-known epigenetic regulator, can epigenetically de-repress the 
anti-apoptotic gene expression. I found that treatment with ethanol significantly 
repressed the expression of AKT1, Bcl2, BIRC5, BIRC6, IGF1R, MCL1, NAIP and 
XIAP. SFN treatment diminished ethanol-induced repression of these genes in 
hNCCs. Treatment with SFN also significantly reduced ethanol-induced increase 
in the enzymatic activity of DNMT in hNCCs. In addition, SFN treatment 
significantly reduced the ethanol-induced hypermethylation at the promoters of 
BIRC5, BIRC6, NAIP, XIAP and Bcl2, suggesting that the aberrant DNA 
methylation induced by ethanol contributes to the downregulation of the anti-
apoptotic genes in ethanol-exposed hNCCs.  
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       To further explore the molecular mechanisms by which ethanol induces the 
aberrant methylation at the promoters of the anti-apoptotic genes, I analyzed the 
protein levels of DNMT1, DNMT3a and DNMT3b, which are the main enzymes 
involved in DNA methylation in mammals142. DNMT1 contributes to maintaining 
the established DNA methylation patterns. DNMT3a and DNMT3b are known as 
de novo methyltransferase and play a role in the establishment of methylation 
patterns during development148. In addition, the defect of DNMT3a was reported 
to result in nonprogressive neurodevelopmental conditions149. Interestingly, 
environmental stimuli, like stress, in the pregnant rat has been found to increase 
DNMT3a expression and alter DNA methylation levels in their offspring150. Study 
has also demonstrated that ethanol exposure increased the expression of 
DNMT3a in rats151. Consistent with these findings, I observed that ethanol 
treatment increased the expression of DNMT3a, which can be diminished by 
treatment with SFN in hNCCs, indicating that upregulation of DNMT3a contributes 
to ethanol-induced hypermethylation at the promoters of anti-apoptotic genes and 
that SFN can diminish ethanol-induced hypermethylation at the promoters of anti-
apoptotic genes by reducing ethanol-induced up-regulation of DNMT3a. Our 
observation is consistent with the study from  Qu X et al., which has shown that 
SFN decreased DNMT3a gene expression in porcine monocyte-derived dendritic 
cells146.  
       Studies from others have demonstrated that DNMT3a can regulate apoptosis-
related genes expression in cancer cells through changing the methylation level at 
the promoter region of the apoptosis-related genes, such as Bad, Bax and Bcl2152-
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154. In the present study, I have found that knockdown of DNMT3a by transfected 
with siRNA-DNMT3a significantly reduced the ethanol-induced down-regulation of 
NAIP and XIAP. The knockdown of DNMT3a also enhanced SFN’s effects on 
promoting the expression of NAIP and XIAP in ethanol-exposed hNCCs. These 
results suggest that the upregulation of DNMT3a contributes to ethanol-induced 
down-regulation of anti-apoptotic genes, NAIP and XIAP, by inducing 
hypermethylation at the promoters of these genes.   
        It has been reported that DNMT inhibitor-induced aberrant methylation at the 
promoters of the anti-apoptotic genes, including ciAP1, ciAP2, Survivin, NAIP and 
XIAP, might be related to apoptosis resistance in cancer cells39. As a DNMT 
inhibitor, SFN has also been shown to promote cell survival in a dose and cell type-
dependent manner. For instance, the study by Qu et al., indicated that SFN 
suppressed the LPS-induced apoptosis in monocyte-derived dendritic cells 
through down-regulating DNMT3a and the suppression of TGF-β signaling146. 
Additionally, previous studies in our laboratory have demonstrated that SFN can 
promote cell survival by upregulating the anti-apoptotic gene, Bcl2, in ethanol 
exposed NCCs18. Treatment with SFN also significantly diminished the ethanol-
induced reduction of Snail1, conferring resistance to apoptosis in NCCs133. In the 
present study, I found that knockdown of DNMT3a significantly decreased 
caspase-3 activation in ethanol-exposed hNCCs and enhanced SFN’s protective 
effects on ethanol-induced apoptosis, suggesting that inhibition of DNMT3a 
contributes to SFN’s protective effects on the ethanol-induced apoptosis in hNCCs. 
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       In summary, the present study indicated that ethanol treatment can inhibit the 
expression of the anti-apoptotic genes, including AKT1, Bcl2, BIRC5, BIRC6, 
IGF1R, MCL1, NAIP and XIAP and that ethanol-induced repression of these anti-
apoptotic genes can be prevented by SFN.  I also observed that SFN diminished 
ethanol-induced up-regulation of DNMT3a and an increase in the enzymatic 
activity of DNMT. Ethanol exposure also resulted in hypermethylation at the 
promoters of the selected anti-apoptotic genes, including BIRC5, BIRC6, NAIP, 
XIAP and Bcl2, which can be prevented by SFN treatment. Knockdown of DNMT3a 
and SFN also significantly diminished the ethanol-induced down-regulation of 
NAIP and XIAP, and subsequently conferring protection against ethanol-induced 
apoptosis in hNCCs. These findings suggest that SFN may represent a promising 
and effective agent for the prevention of ethanol-induced apoptosis and FASD.
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CHAPTER IV 
 
SULFORAPHANE PREVENTS HUMAN NEURAL CREST CELLS FROM 
ETHANOL-INDUCED APOPTOSIS THROUGH DIMINISHING ETHANOL-
INDUCED REDUCTION OF HISTONE ACETYLATION  AT THE 
PROMOTER OF THE ANTI-APOPTOTIC GENES 
 Introduction 
     Maternal ethanol exposure during pregnancy could result in physical and 
behavioral abnormalities in the offspring, which is defined as fetal alcohol spectrum 
disorder (FASD)128, 129, 155. Exposure of mouse or chicken embryos to ethanol 
during a certain period of development can also cause craniofacial abnormalities 
associated with FASD14, 131, 156. Extensive research with mice or chicken embryos 
revealed that exposure to ethanol could induce excessive cell death in neural crest 
cells (NCCs)130, 157, 158. Studies in our lab also shown ethanol exposure increased 
apoptosis in NCCs and that ethanol-induced apoptosis in NCCs contributes heavily 
to ethanol-induced malformations132, 133. The molecular mechanisms underlying 
FASD that result from prenatal alcohol exposure are poorly understood. Studies 
have shown that ethanol can induce modifications in DNA22-24 and histones25, 27-29, 
and such changes may mediate the detrimental effects of prenatal alcohol 
exposure and contribute to the abnormalities associated with FASD. The first study 
on the role of histone modification in alcohol-induced damages was conducted on 
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liver cells. This study found that H3K9ac was increased in a time- and dose-
dependent manner after ethanol exposure159, 160. Furthermore, it has also been 
reported that chronic alcohol exposure in humans resulted in global increases in 
the levels of histone 3 at lysine 4 (H3K4me3)161. Histone acetylation and 
methylation play a critical role in the regulation of the expression of the genes 
involved in cell cycle progression and apoptosis162, 163. For instance, study has 
shown that prenatal alcohol exposure decreased histone H3K9 acetylation at the 
promoter regions of the anti-apoptotic gene Bcl2, resulting in the downregulation 
of Bcl2 and  apoptosis in fetal myocyte164. Taken together, these works indicated 
that ethanol-induced epigenetic modulation of apoptosis-related genes could be 
an important mechanism underlying the pathogenesis of FASD. 
       The complexes of nuclear DNA and proteins are called chromatin. In 
chromatin, the fundamental repeat unit is the chromosome, consisting of one 
octamer comprised of four core histone proteins (H2A, H2B, H3 and H4) around 
which 147 base pairs of DNA are wrapped48. Each of the core histones has an N-
terminal “tail” that can be subject to several covalent modifications associated with 
euchromatic (open) and heterochromatin (close) chromatin states. These covalent 
modifications are established by “writers”, such as histone lysine 
methyltransferases (KMTs), histone acetyltransferases (HATs). These 
modifications can be removed by “erasers,” such as histone demethylases (KDMs), 
histone deacetylases (HDACs)165. HATs and HDACs are associated with histone 
acetylation and deacetylation, representing transcriptional activation or repression, 
respectively166, 167. There are 18 HDACs in human, and they are distributed into 4 
61 
 
classes: class I HDACs (1, 2, 3 and 8), class II HDACs (4, 5, 6, 7 and 9), and class 
IV HDACs are all dependent upon zinc for activity, whereas class III HDACs are 
structurally unique because they need NAD+ for enzymatic activity168, 169. The 
histone deacetylase inhibitor (HDACi) can interfere with the deacetylase function 
of HDAC, improving the acetylation of histone and activating gene expression. 
Substantial studies have indicated that the HDACi are emerging as a prominent 
class of therapeutic agents for the treatment of a variety of cancers, such as 
pancreatic, ovarian, breast, colon, prostate, and thyroid cancer59-62. Other studies 
have also demonstrated that HDACi has important neuroprotective effects in the 
prevention or treatment of nervous system diseases64-66. HDACi is also known to 
inhibit apoptosis, increase cell survival and enhance anti-inflammatory response64, 
65, 68, 69. The study from Dr. Zhang has shown that the HDACi valproic acid (VPA) 
protected against neuronal apoptosis by activating BNDF-TrkB signaling at the 
transcriptional level, VPA treatment also resulted in the hyperacetylation of histone 
H3K14 at the promoter regions of BNDF, and promoted transcriptional activity71. 
VPA has also been shown to upregulate the expression of anti-apoptotic gene 
Hsp70 by enhancing the acetylation of histone H3 at Hsp70 promoter68. These 
results demonstrate that HDACis might be used as protective agents to regulate 
the apoptosis-related genes and prevent ethanol-induced apoptosis.  
       Sulforaphane (SFN) is a vegetable-derived isothiocyanate that is abundant in 
cruciferous vegetables such as broccoli. Compelling evidence indicated that SFN 
can prevent cancer and other diseases through its regulatory role on the tumor cell 
cycle, apoptosis and angiogenesis112, 170-172. Interestingly, our previous studies 
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have shown that SFN exerts an anti-apoptotic effect through upregulating the anti-
oxidant gene Nrf2 in NCCs17. Recent studies have shown that SFN can inhibit 
HDACs, the enzyme involved in histone deacetylation115, 117, 173. Moreover, some 
other study has shown the metabolite of SFN, SFN-cysteine, can interact with the 
active site of HDAC, which subsequently inhibits HDAC activity174. SFN was found 
to inhibit LPS-induced HDAC6, HDAC10 and DNMT3a gene expression, 
conferring resistance to LPS-induced apoptosis in porcine monocyte-derived 
dendritic cells146. Our recent study has also shown SFN can prevent ethanol-
induced apoptosis in NCCs by diminishing ethanol-induced reduction of histone 
acetylation at the promoter of the anti-apoptotic gene, Bcl218. We have also 
demonstrated that SFN treatment prevented the ethanol-induced reduction of 
H3K4me3 on the promoters of Snail1, a key transcriptional factor of epithelial to 
mesenchymal transition (EMT), and prevented ethanol-induced apoptosis in 
NCCs133.  
       In the present study, I tested the hypothesis that SFN can reverse ethanol-
induced apoptosis through epigenetic upregulation of the anti-apoptotic genes. I 
found that SFN can diminish the ethanol-induced increase in the enzymatic activity 
of HDAC and up-regulation of HDAC2. Treatment with SFN also diminished 
ethanol-induced reduction of H3 acetylation at the promoters of AKT1, BIRC6 and 
XIAP, resulting in increased expression of AKT1, BIRC6 and XIAP in ethanol 
exposed hNCCs. Knockdown of HDAC2 can also prevent ethanol-induced 
repression of these genes, enhancing SFN’s protective effects on the expression 
of anti-apoptotic genes in ethanol-exposed hNCCs. I have also demonstrated that 
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SFN and knockdown of HDAC2 can protect hNCCs against ethanol-induced 
apoptosis. These results demonstrate that SFN can significantly prevent ethanol-
induced apoptosis in hNCCs through epigenetically upregulating the anti-apoptotic 
genes. 
 Experimental Procedures 
  Cells treatments 
            hNCCs were pretreated with or without 1 µM SFN for 24 hours, followed 
by concurrent exposure to 1 µM SFN and 50 mM ethanol in a plastic desiccator 
containing 50 mM ethanol in distilled water. 
  ChIP-qRT-PCR analysis 
            ChIP experiments were performed as described in Chapter II, C. 4. 
Chromatin was immunoprecipitated with antibodies to H3ac. The qPCR was 
carried out with primers shown in Chapter II, C.4.µµ 
  Quantitative real-time PCR 
            mRNA expression of AKT1, BIRC6, and XIAP were measured by 
quantitative RT-PCR, as described in Chapter II, Section C. 2. 
  Western Blotting 
            The protein level of H3Ac, Cleaved caspase-3, HDAC1, HDAC2, HDAC3, 
Histone H3, AKT1, BIRC6, and XIAP were determined by western blotting as 
described in Chapter II, Section C. 3. 
  Analysis of HDAC activity 
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            The nuclear protein was extracted from the control and treated hNCCs by 
using the EpiQuik Nuclear Extraction Kit (Epigentek) according to the 
manufacturer’s protocol. The HDAC activity was measured using an HDAC 
fluorometric activity assay kit (Enzo), in which an established HDAC inhibitor TSA 
was taken as a control. 10 µg of nuclear extract was incubated with or without 
inhibitor for 1 hour at 37 ºC and then stoped by the addition of the developer for 
further 10-15 min. The absorbance was read on fluorimeter at 360 nm   excitation 
and 460 nm emission wavelength.   
  HDAC2 siRNA transfection 
            For HDAC2 siRNA transfection, hNCCs were transfected with HDAC2 
siRNA or scrambled control siRNA in a final concentration of 25 nM as described 
in Chapter II, Section C. 7 
 Statistical analysis 
     Statistical analysis was performed as described in Chapter II, Section D. 
C. Results 
1. SFN diminished the ethanol-induced increase HDAC activity and the 
up-regulation of HDAC2 in hNCCs.  
           To determine the effects of ethanol and SFN on HDAC activity, hNCCs were 
pretreated with or without 1 μM SFN for 24 hours, followed by concurrent exposure 
to 1 μM SFN or 50 mM ethanol for additional 24 hours. We found that exposure to 
ethanol alone for 24 hours significantly increased the activity of HDAC in hNCCs.  
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Co-treatment with SFN significantly reduced the ethanol-induced increase in the 
activity of HDAC. In addition, ethanol exposure resulted in a significant increase in 
the protein expression of HDAC2 in hNCCs. Treatment with SFN dramatically 
reduced the up-regulation of HDAC2 in hNCCs exposed to ethanol (Figure 4.1A, 
B). These results suggest that HDAC2 may contribute to the ethanol-induced 
reduction of histone acetylation at the promoters of the anti-apoptotic genes in 
hNCCs.   
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Figure 4. 1. SFN treatment significantly decreased HDAC activity and HDAC2 
expression in ethanol-exposed hNCCs. hNCCs were pre-treated with 1 µM SFN 
for 24 hours and then co-treated with 1 µM SFN and 50 mM ethanol for an 
additional 24 hours. (A) The nuclear protein was isolated from control and treated 
hNCCs, and the HDAC activity was determined as described in methods. (B) The 
protein expression of HDAC1, HDAC2, and HDAC3 in control and treated hNCCs 
was determined by Western blot. Data are expressed as fold change over control 
and represent the mean ± SEM of three separated experiments. *p<0.05. 
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2. SFN diminished the ethanol-induced reduction of H3 acetylation at the 
promoters of the selected anti-apoptotic genes in hNCCs. 
           To determine whether ethanol-induced increase in HDAC activity and up-
regulation of HDAC2 can result in the reduction of H3 acetylation at the promoters 
of the selected anti-apoptotic genes and whether SFN that can inhibit HDAC 
activity and diminish ethanol-induced up-regulation of HDAC2 can prevent 
ethanol-induced reduction of H3 acetylation at the promoters of anti-apoptotic 
genes, the expression of acetylated histone H3 was determined by western blot. 
We found that ethanol exposure significantly decreased the levels of acetylated 
histone H3 in hNCCs. Co-treatment with SFN diminished the reduction of 
acetylated histone H3 in ethanol-exposed hNCCs. We then tested whether ethanol 
exposure can decrease the acetyl-histone H3 binding to the promoters of the 
identified anti-apoptotic genes in hNCCs by using ChIP-qPCR. Exposure to 
ethanol significantly decreased the binding of acetylated histone H3 to the 
promoters of AKT1, BIRC6 and XIAP. Co-treatment with SFN significantly 
diminished ethanol-induced reduction of the binding of acetylated histone H3 to 
the promoters of these anti-apoptotic genes in hNCCs (Figure 4.2B). These results 
demonstrated that ethanol exposure can reduce the binding of acetylated histone 
H3 to the promoters of the selected anti-apoptotic genes in hNCCs, which can be 
prevented by SFN. 
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Figure 4. 2. SFN increased acetyl-histone H3 protein levels and histone H3 
acetylation at the promoters of AKT1, BIRC5, and XIAP in ethanol-exposed hNCCs. 
hNCCs were pre-treated with 1 µM SFN for 24 hours and followed by 24 hours of 
concurrent exposure of 1 µM SFN and 50 mM ethanol. (A) The acetyl-histone H3 
protein expression was determined by using Western blot. (B) The schematic 
depiction of the promoter regions of each gene and primer sets for chip experiment. 
Acetyl-histone H3 enrichment at corresponding sites (P1-P3) was determined by 
ChIP-qPCR. Data are expressed as fold change over control (A) or percentage of 
input (B) and represent the mean ± SEM of three separated experiments. *p<0.05. 
TSS: Transcriptional start site. 
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3. SFN treatment diminished ethanol-induced down-regulation of AKT1, 
BIRC6, and XIAP in ethanol-exposed hNCCs  
           To determine whether SFN-induced increase in acetylation at the 
promoters of AKT1, BIRC6 and XIAP leads to the diminished down-regulation of 
of these genes in ethanol-exposed hNCCs, the mRNA expression of AKT1, BIRC6 
and XIAP was determined by using quantitative RT-PCR. The result has shown 
that ethanol exposure significantly decreased the mRNA expression of AKT1, 
BIRC6 and XIAP in hNCCs. SFN treatment significantly diminished the ethanol-
induced down-regulation of these genes (Figure 4.3). 
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Figure 4. 3. SFN treatment significantly increased the mRNA expression of 
AKT1, BIRC6 and XIAP in ethanol-exposed hNCCs. hNCCs were pre-treated 
with 1 µM SFN for 24 hours and then co-treated with 1 µM SFN and 50 mM 
ethanol for an additional 24 hours. The mRNA expression of AKT1, BIRC6 and 
XIAP was determined by quantitative RT-PCR. Data are expressed as fold 
change over control and represent the mean ± SEM of three separated 
experiments. 
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4. Knockdown of HDAC2 prevented ethanol-induced down-regulation of 
AKT1, XIAP and BIRC6 in hNCCs. 
           To confirm that HDAC2 contributes to the ethanol-induced reduction of the 
binding of acetylated histone H3 to the promoters of the selected anti-apoptotic 
genes and subsequent down-regulation of these genes, HDAC2 was knocked 
down by siRNA in hNCCs before treatment with ethanol and SFN. We found that 
ethanol exposure resulted in a significant decrease in mRNA expression of AKT1, 
BIRC6 and XIAP. Protein expression of AKT1, BIRC6 and XIAP was also 
decreased in ethanol-exposed hNCCs. The knockdown of HDAC2 significantly 
diminished ethanol-induced decreases in the mRNA and protein expression of 
AKT1, BIRC6 and XIAP. The knockdown of HDAC2 also enhanced the effects of 
SFN on the mRNA and protein expression of AKT1, BIRC6 and XIAP (Figure 4.4A, 
B).  These results demonstrate that knockdown of HADC2 can diminish ethanol-
induced repression of anti-apoptotic genes in hNCCs.   
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Figure 4. 4. Knockdown of HDAC2 prevented ethanol-induced down-regulation of 
AKT1, XIAP and BIRC6 in hNCCs. hNCCs transfected with control-siRNA or 
HDAC2-siRNA were treated with 1µM SFN or 50 mM ethanol or co-treated with 
SFN and ethanol for 24 hours. (A) The mRNA expressions of AKT1, BIRC5, and 
XIAP were determined by quantitative RT-PCR. (B) The protein level of AKT1, 
BIRC5 and XIAP were determined by western blotting. Data are expressed as fold 
change over control and represent the mean ± SEM of three separated 
experiments. *p < 0.05, **p<0.01, ***p<0.001. 
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5. The knockdown of HDAC2 and SFN treatment prevented ethanol-
induced apoptosis in hNCCs.  
          To determine whether ethanol-induced up-regulation of HDAC2 and 
subsequent reduction of the binding of acetylated histone H3 to the promoters of 
the selected anti-apoptotic genes and repression of these genes contribute to 
ethanol-induced apoptosis and whether SFN can prevent ethanol-induced 
apoptosis by diminishing ethanol-induced up-regulation of HDAC2, HDAC2 was 
knocked down by siRNA in hNCCs. We found that ethanol exposure significantly 
increased apoptosis in hNCCs. The knockdown of HDAC2 by siRNA or down-
regulation of HDAC2 by SFN significantly diminished ethanol-induced apoptosis in 
hNCCs (Figure 4.5). These results demonstrate that ethanol-induced up-regulation 
of HDAC2 contributes to ethanol-induced apoptosis and that SFN can prevent 
ethanol-induced apoptosis in hNCCs by diminishing ethanol-induced up-regulation 
of HDAC2.     
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Figure 4. 5. The knockdown of HDAC2 by siRNA or SFN treatment prevented 
ethanol-induced apoptosis in hNCCs. hNCCs transfected with siRNA-HDAC2 or 
siRNA-control were treated with 1 µM SFN or 50 mM ethanol or co-treated with 
ethanol and SFN for an additional 24 hours, the protein expression of HDAC2 and 
cleaved caspase-3 were determined by Western blotting. Data are expressed as 
fold change over control and represent the mean ± SEM of three separated 
experiments. *p < 0.05, **p<0.01. 
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D. Discussion 
     A recent study has shown that SFN can epigenetically restore the expression 
of Bcl2 and attenuating ethanol-induced apoptosis by enhancing the acetylation 
levels on histone H3 at the promoter of Bcl218. The results from this study have 
shown that treatment with SFN significantly decreased the enzymatic activity of 
HDACs in ethanol-exposed hNCCs, which is consistent with the results from our 
and other’s work18, 125, 175. I also found that ethanol exposure decreased the histone 
H3 acetylation, suggesting that ethanol-induced inhibition of HDACs activity is 
associated with a decrease in histone H3 acetylation levels. This result was 
supported by the study that has shown that ethanol-induced increase in whole 
hippocampus HDAC activity was related to a decrease in histone H3 acetylation 
levels176. I also found that treatment with SFN significantly diminished the ethanol-
induced decrease in histone H3 acetylation. In addition, ethanol exposure 
significantly reduced the level of histone H3 acetylation at the promoters of AKT1, 
BIRC6 and XIAP. Treatment with SFN prevented ethanol’s effect on the histone 
H3 acetylation at the promoters of AKT1, BIRC6 and XIAP.  
       To further explore the molecular mechanisms underlying the changes of 
histone H3 acetylation at the promoters of anti-apoptotic genes, I have analyzed 
the protein levels of HDAC1, HDAC2 and HDAC3. These three HDACs belong to 
the class I HDACs, which are expressed in all tissues and localized mainly in the 
nucleus. It was reported that class I HDACs were associated with embryonic 
lethality177 and that HDAC2 has been shown to be a crucial molecule to preserve 
hippocampal memory and normal cognitive function166. The study by Xiang B et 
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al., has also demonstrated that HDAC2 was involved in regulating early brain 
development178. Here, I found that ethanol exposure significantly increased 
HDAC2 expression in hNCCs. This result is consistent with the in vivo study 
showing that an increase in HDAC2 expression in aged male offspring after 
maternal consumed ethanol during periconceptional period179, as well as an in vitro 
study demonstrating that ethanol treatment can increase HDAC2 expression in a 
dose-dependent manner in the human neuronal cell line180. Interestingly, the 
HDAC inhibitor, trichostatin (TSA) can attenuate alcohol-drinking behaviors, with a 
concomitant reduction in the expression of HDAC2181. HDAC inhibitor also 
significantly inhibited the ethanol-induced increase of HDAC2180. Consistent with 
these findings, I have found that SFN, as an HDAC inhibitor, can decrease the 
ethanol-induced increase in HDAC2 expression and HDAC activity in hNCCs. 
      Previous studies have shown that HDACs can modulate acetylation within 
given gene promoters and regulate the transcription of the specific genes. For 
example, HDAC inhibitor VPA upregulated the expression of anti-apoptotic gene 
Hsp70 by enhancing the acetylation of histone H3 at Hsp70 promoter68. In addition, 
in ethanol-exposed adulthood rat, high HDAC activity and HDAC2 expression and 
deficits in histone H3 acetylation at the promoters of brain-derived neurotrophic 
factor (BDNF) and decreased expression of BDNF were observed, which were 
reversed by knockdown of HDAC2 using  TSA176. In the present study, I found that 
knockdown of HDAC2 by transfected with siRNA-HDAC2 significantly increased 
the expression of AKT1, XIAP and BIRC6 at both mRNA and protein levels, and it 
can also enhance SFN’s effects on promoting the expression of AKT1, XIAP and 
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BIRC6 in ethanol-exposed hNCCs. These results suggest that ethanol-induced up-
regulation of HDAC2 and an increase in HDAC activity contribute to ethanol-
induced down-regulation of the anti-apoptotic genes in hNCCs.   
      Increasing evidence has shown that the downregulation of HDACs can 
alleviate apoptosis in vitro and in vivo68, 182, 183. For example, Marisela et al., has 
reported that HDAC2 inhibitor TSA exerted a neuroprotective effect through 
reducing ethanol-induced excessive ROS180. Furthermore, inhibition of HDAC2 by 
its inhibitor CAY10683 offers a protective effect on inhibiting apoptosis in mouse 
model183. As an HDAC inhibitor, SFN can also inhibit LPS-induced apoptosis in 
monocyte-derived dendritic cells, accompanied by a reduction of HDAC activity 
and the expression of HDAC6 and HDAC10118. Additionally,  our recent  study has 
shown that SFN can prevent ethanol-induced apoptosis through inhibiting HDAC 
activity and increase the level of histone H3 acetylation at the promoter of Bcl218. 
Consistent with these findings, I have found that knockdown of HDAC2 significantly 
decreased caspase-3 activation in ethanol-exposed hNCCs and enhanced SFN’s 
protective effects on ethanol-induced apoptosis in hNCCs, suggesting that SFN 
can diminish hNCCs from ethanol-induced apoptosis by inhibiting HDAC2.  
       In summary, the present study indicated that treatment with SFN significantly 
decreased the ethanol-induced increase in the enzymatic activity of HDACs and 
inhibited ethanol-induced upregulation of HDAC2. Treatment with ethanol 
significantly decreased acetylation of histone H3 at the promoter of AKT1, BIRC6 
and XIAP, which can be prevented by co-treatment with SFN. Diminished 
reduction of acetylation at the promoters of AKT1, BIRC6 and XIAP induced by 
78 
 
SFN reduced ethanol-induced down-regulation of these genes in ethanol-exposed 
hNCCs. Knockdown of HDAC2 also prevented the ethanol-induced down-
regulation of AKT1, BIRC6 and XIAP, and subsequently prevented apoptosis in 
ethanol-exposed hNCCs. These findings demonstrate that SFN can diminish 
ethanol-induced apoptosis in hNCCs by modulating HDAC2 and diminishing 
histone acetylation at the promoters of the selected anti-apoptotic genes. 
79 
 
CHAPTER V 
 
SULFORPHANE PROTECTS AGAINST ETHANOL-INDUCED APOPTOSIS IN 
NEURAL CREST CELLS AND ZEBRAFISH EMBRYOS THROUGH 
MODULATING HISTONE METHYLATION AND THE EXPRESSION OF SNAIL1 
AND RESTORING EMT 
 Introduction 
      Fetal Alcohol Spectrum Disorder (FASD) is a major developmental defect 
caused by alcohol consumption by women during pregnancy. FASD is 
characterized by craniofacial abnormalities, mental retardation and behavior 
defect184-186. Studies have demonstrated that ethanol-induced excessive cell death 
in the specific cell population is one of the major mechanisms underlying the 
pathogenesis of FASD187, 188. Our studies and others have shown that ethanol can 
induce apoptosis in neural crest cells (NCCs) and that ethanol-induced apoptosis 
in NCCs contributes significantly to ethanol-induced malformations132, 155, 189.  
     NCC is a multipotent and migratory progenitor cell population that originates 
between the neural plate and non-neural ectoderm10. After induction at the border 
of the neural plate, NCCs leave their original location through a delamination 
process and migrate ventrally to differentiate into a diversity of neural and non-
neural cell types, including neuron, glia, craniofacial cartilage, bone and connect 
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tissue91-93, 190. NCC delamination process involves epithelial-to-mesenchyme 
transition (EMT). EMT is a process that orchestrates a change from an epithelial 
to a mesenchymal phenotype, a process that increases migratory properties, 
invasiveness and apoptotic resistance95, 96. EMT is essential for both normal 
development and cancer invasion and metastasis97-99. During embryonic 
development, NCCs undergo an EMT and then dissociate from the neural folds 
and differentiate to a diversity of cell types10, 91, 93. EMT also plays a pivotal role in 
promoting tumor proliferation, invasion, and metastasis, exerting an anti-apoptosis 
effect100, 191. Studies have shown that EMT conferred resistance to UV-induced 
apoptosis in three murine mammary epithelial cell lines102. Park et al. have also 
shown that α-mangostin can inhibit EMT and induce apoptosis in an osteosarcoma 
cell line103. However, the roles of EMT in ethanol-induced apoptosis in NCCs and 
in the pathogenesis of FASD remain to be defined. 
      One of the well-known transcriptional factors that regulate EMT is Snail1104-106. 
Snail1 promotes EMT primarily through the directly repressing E-cadherin, an EMT 
suppressing factor104, 107, 192. The expression of Snail1 can be regulated by many 
mechanisms, including epigenetic regulation. Epigenetic modification generally 
includes DNA methylation and histone modification, which includes histone 
acetylation and methylation48. Among the histone methylation, the triple methyl 
modification on the fourth lysine of histone 3 (H3K4me3) typically facilitates the 
activation of gene transcription72, while lysine demethylase 5A (KDM5A), the 
member of KDM superfamily, has been shown to specifically catalyzing the 
removal of tri-methyl from H3K4 and initiating the transcriptional repression 
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process193-195. Previous studies have established that KDM5A can cooperate with 
different transcriptional factors to selectively repress gene transcription193, 195-197. 
Given the intimate association between H3K4 methylation and 
neurodevelopmental disorder, it is rational to assume that KDMs that are 
responsible for demethylation of H3K4me associated with neurodevelopmental 
disorder 194, 198, 199.  
     Sulforaphane (SFN) is a vegetable-derived isothiocyanate that is abundant in 
cruciferous vegetables such as broccoli. Our previous studies have shown that 
SFN exerts an anti-apoptotic effect through upregulating antioxidant gene Nrf-2 in 
NCCs17. Our recent studies have also shown that SFN can prevent ethanol-
induced apoptosis in NCCs by reversing ethanol-induced reduction of histone 
acetylation at the promoter of the anti-apoptotic gene, Bcl218. More recently, SFN 
had been reported to act as an inhibitor of histone deacetylase (HDAC) and DNA 
methyltransferase (DNMT), two key enzymes involved in histone deacetylation 
and DNA methylation, respectively, to cause epigenetic modification of genes in 
varied types of cells, including the genes involved in EMT in cancer cells 115-117. 
Interestingly, studies have also shown that HDAC inhibitor also has a high 
inhibitory effect on KDMs200 and that HDAC inhibitor decreased KDM5A 
expression and modulated the expression of histone markers H3Ac and 
H3K4me3201. However, the role of SFN and KDMs in the epigenetic regulation of 
EMT transcriptional factors and ethanol-induced apoptosis in NCCs remains 
unknown.  
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       In the present study, I tested the hypothesis that SFN can protect against 
ethanol-induced apoptosis by restoring EMT through epigenetically modulating the 
expression of Snail1 in NCCs. I found that treatment with SFN significantly 
reversed ethanol-induced changes in the expression of E-cadherin, and restored 
EMT in NCCs. I also found that ethanol exposure significantly reduced the levels 
of H3K4me3 at the promoters of Snail1. SFN treatment reduced the ethanol-
induced reduction of H3K4me3 at the promoter regions of the Snail1 gene and 
restored Snail1 gene expression and EMT. In addition, I found that ethanol 
exposure increased the expression of KDM5A, which was decreased by co-
treatment with SFN. Knockdown KDM5A by siRNA prevented the ethanol-induced 
decrease of H3K4me3 enrichment at Snail1 promoter, restored Snail1 gene 
expression and subsequently restored EMT in NCCs exposed to ethanol. I have 
also found siRNA mediated downregulation of KDM5A dramatically diminished 
ethanol-induced apoptosis in NCCs as well as zebrafish embryos. These results 
demonstrate that ethanol exposure can induce apoptosis in NCCs by inhibiting 
EMT and that SFN can protect against ethanol-induced apoptosis by epigenetically 
regulating the expression of Snail1 and restoring EMT.  
 Experimental procedures 
  Cell culture and treatment 
            NCCs (JoMa 1.3 cell) were cultured on culture dishes coated with 
fibronectin. NCCs were treated with SFN and ethanol, as described in Chapter II, 
Section A. 
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  Quantitative real-time PCR 
            The mRNA expression of Snail1, KDM5A, E-cadherin, Vimentin, and 
Snail1 were measured by quantitative real-time RT-PCR as described in Chapter 
II, Section C. 2. 
  Western blot analysis 
            The protein level of KDM5A, H3K4me3, H3, E-cadherin, Vimentin, Cleaved 
caspase-3, and Snail1 were determined by western blotting as described in 
Chapter II, Section C. 3. 
  Chip-qRT-PCR analysis 
            ChIP experiments were performed as described in Chapter II, C. 4. 
Chromatin was immunoprecipitated with antibodies to H3K4me3. The qRT-PCR 
was carried out with primers shown in Chapter II, C. 4. 
  TUNEL staining 
            Analysis of apoptosis in 24 hpf zebrafish embryos of control and 
experimental groups was performed by using TUNEL staining as described in 
Chapter II, B. 3. 
  Flow cytometry 
            Apoptosis in NCCs was determined by using Flow cytometry, as described 
in Chapter II, C. 5. 
 siRNA Knockdown of KDM5A and Snail1 
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           For Snail1 or KDM5A siRNA transfection, NCCs were transfected with 
Snail1 siRNA, KDM5A siRNA or scrambled control siRNA as described in Chapter 
II, C. 7. 
  Statistical analysis 
            Statistical analysis was performed, as described in Chapter II, C. 8. 
C. Results 
1. Ethanol exposure induced apoptosis in NCCs 
          To determine whether ethanol exposure can induce apoptosis in NCCs, 
NCCs were exposed to 50 or 100 mM ethanol, and ethanol-induced apoptosis was 
determined by the analysis of caspase-3 activation and Annexin V staining. As 
shown in Figure 5.1A, ethanol exposure resulted in significant increases in 
caspase-3 activation in a dose-dependent manner, indicating that ethanol 
treatment can induce apoptosis in NCCs. This result was confirmed by the results 
from the flow cytometric analysis of Annexin V staining, which have shown that 
exposure of NCCs to 50 or 100 mM ethanol caused a substantial increase in the 
number of early apoptotic NCCs (Figure 5.1B) 
 
 
85 
 
 
Figure 5. 1. Ethanol exposure induced apoptosis in NCCs.  NCCs were exposed 
to 50 or 100 mM ethanol for 24 h. Apoptosis was determined by the analysis of 
caspase-3 cleavage by western blotting (A, B) or flow cytometry with Annexin V-
FITC apoptosis detection kit (B). Data are expressed as fold change over control 
(A) or percentage of all cells (B) and represent the mean ± SEM of three separated 
experiments. *p<0.05, **p<0.01. 
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2.  SFN diminished ethanol-induced inhibition of EMT in NCCs 
            To determine whether ethanol exposure can induce apoptosis in NCCs by 
inhibiting EMT and whether SFN can protect NCCs against apoptosis through 
restoring EMT, NCCs were cultured with 1 µM SFN alone for 24 hours, followed 
by 24 hours of concurrent exposure to 1 µM SFN and 50 mM ethanol. As shown 
in Figure 5. 2, ethanol treatment significantly inhibited EMT in NCCs, as indicated 
by the increased expression of E-cadherin, an EMT-suppressing marker, and a 
decreased expression of vimentin, an EMT-promoting marker. Treatment with SFN 
significantly reversed ethanol-induced changes in the expression of E-cadherin 
and vimentin and restored EMT in NCCs. These results indicate that ethanol 
exposure can inhibit EMT in NCCs, which can be reversed by SFN. 
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Figure 5. 2. SFN diminished ethanol-induced EMT inhibition in NCCs.  NCCs were 
pre-treated with 1 μM SFN for 24 h and followed by 24 h of concurrent exposure 
to SFN and ethanol. The expression of EMT-suppressing factor E-cadherin and 
EMT-promoting factor vimentin was determined by western blotting. Data are 
expressed as fold change over control and represent the mean ± SEM of three 
separated experiments. *p < 0.05, **p<0.01. 
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3. SFN diminished the ethanol-induced increases in the mRNA and 
protein expression of KDM5A in NCCs. 
           KDM5A, a histone demethylase, has been shown to directly remove tri-
lysine of histone H3193, 194, 202. To determine whether KDM5A is involved in the 
ethanol-induced alteration in histone methylation, the expression of KDM5A was 
determined in control and ethanol-exposed NCCs.  As shown in Figure 5.3A, B, 
qRT-PCR and Western blot analysis revealed a significant increase in the mRNA 
and protein expression of KDM5A in ethanol-exposed NCCs. Co-treatment with 
SFN and ethanol diminished the ethanol-induced up-regulation of KDM5A in NCCs.  
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Figure 5. 3. SFN diminished ethanol-induced increases in the mRNA and protein 
expression of KDM5A in NCCs. NCCs were pretreated with 1 µM SFN for 24 h and 
followed by 24 h of concurrent exposure to SFN and 50 mM ethanol for 24 h. (A) 
The mRNA expression of KDM5A was determined by quantitative RT-PCR. (B) 
Protein expression of KDM5A was determined by western blotting. Data are 
expressed as fold change over control and represent the mean ± SEM of three 
separated experiments. *p<0.05, **p<0.01. 
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4. SFN treatment diminished the ethanol-induced reduction in the 
H3K4me3 enrichment at the promoter regions of the Snail1 gene in 
NCCs. 
           Snail1 is a key transcriptional repressor of E-cadherin and plays an 
important role in the regulation of EMT104, 107, 192. To determine the mechanisms by 
which ethanol inhibits EMT and SFN diminishes the ethanol-induced inhibition of 
EMT in NCCs, I next determined whether ethanol and SFN can modulate EMT 
through epigenetically regulating the expression of Snail1. I first determined 
whether ethanol exposure can reduce the H3K4 trimethylation (H3K4me3), an 
epigenetic modification that is associated with the activation of transcription of 
genes72, 203. As shown in Figure 5.4A, exposure to 50 mM ethanol resulted in a 
significant decrease in the levels of H3K4me3 in NCCs. Co-treatment with SFN 
and ethanol significantly increased the H3K4me3 expression in NCCs, indicating 
that ethanol-induced reduction of H3K4 trimethylation in NCCs can be diminished 
by SFN. In addition, the ChIP-qPCR analysis revealed that ethanol exposure 
resulted in a significant reduction of H3K4me3 enrichment at the promoter regions 
of Snail1. SFN can diminish the ethanol-induced reduction of H3K4me3 
enrichment at the promoter regions of Snail1 (Figure 5.4C). 
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Figure 5. 4. SFN diminished the ethanol-induced reduction of the levels of 
H3K4me3 at the Snail 1 promoter. (A) The levels of H3K4me3 in control and 
treated NCCs were determined by western blot.  (B) Schematic depiction of the 
Snail1 promoter and the primer sets for ChIP-qPCR analyses. (C) H3K4me3 
enrichment at corresponding sites (P1-P5) was determined by ChIP-qPCR. Data 
are expressed as fold change over control (A) or the percentage of input (C) and 
represent the mean ± SEM of three separated experiments *p < 0.05. TSS: 
Transcriptional start site. 
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5. SFN treatment restored the expression of Snail1 in ethanol-exposed 
NCCs 
           I next tested whether the ethanol-induced reduction of H3K4me3 
enrichment at the promoter regions of Snail1 can downregulate the Snail1 and 
whether SFN treatment can restore the expression of Snai1 in ethanol-exposed 
NCCs. As expected, qRT-PCR and Western blot analysis revealed a significant 
decrease in the mRNA and protein expression of Snail1 in ethanol-exposed NCCs. 
Treatment with SFN restored the mRNA and protein expression of Snail1 in NCCs 
exposed to ethanol (Figure 5.5). This result demonstrates that SFN can prevent 
ethanol-induced down-regulation of Snail1 in NCCs. 
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Figure 5. 5. SFN restored Snail1 expression in ethanol-exposed NCCs. NCCs 
were exposed to 1 µM SFN for 24 h, followed by concurrent exposure to 1 µM SFN 
and 50 mM ethanol for 24 h. The expression of Snail1 mRNA (A) and protein (B) 
was determined by quantitative RT-qPCR and Western blot, respectively. Data are 
expressed as fold change over control and represent the mean ± SEM of three 
separated experiments. *p<0.05, **p<0.01. 
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6. Treatment with SFN significantly decreased the up-regulation of 
Snail1 target gene E-cadherin in NCCs exposed to ethanol 
           To determine whether ethanol-induced down-regulation of Snail1 can 
increase the expression of E-cadherin, a Snail1 target gene and an EMT 
suppressing marker, in NCCs and whether SFN can diminish ethanol-induced up-
regulation of E-cadherin, the mRNA expression of E-cadherin was determined in 
control and treated NCCs. As shown in Figure 5.6, exposure of NCCs to ethanol 
resulted in a significant increase in E-cadherin expression. Treatment with SFN 
significantly diminished ethanol-induced up-regulation of E-cadherin in NCCs. 
Since the down-regulation of E-cadherin is considered to be a hallmark of EMT106, 
204, these results demonstrate that SFN can prevent ethanol-induced inhibition of 
EMT in NCCs. 
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Figure 5. 6. SFN diminished the expression of Snail1 target gene E-cadherin in 
ethanol-exposed NCCs. NCCs were pre-treated with 1 μM SFN for 24 h and then 
exposed to 1 μM SFN and 50 mM ethanol for an additional 24 h. The expression 
of E-cadherin mRNA was determined by quantitative RT-PCR. Data are expressed 
as fold change over control and represent the mean ± SEM of three separated 
experiments. *p < 0.05. 
 
 
 
 
 
 
 
 
96 
 
7. SFN treatment significantly diminished ethanol-induced apoptosis in 
NCCs through up-regulation of Snail1 
           To determine whether SFN can prevent ethanol-induced apoptosis, 
caspase-3 activation and Annexin V staining were examined in control and treated 
NCCs. As shown in Figure 5.7A, exposure of NCCs to ethanol resulted in a 
significant increase in caspase-3 activation, indicating that ethanol exposure 
induced apoptosis in NCCs. Treatment with SFN significantly reduced caspase-3 
activation in NCCs exposed to ethanol. To further confirm that SFN can diminish 
ethanol-induced apoptosis through up-regulation of Snail1, apoptosis was 
analyzed by the flow cytometric analysis of Annexin V staining in NCCs transfected 
with control or Snail1 siRNA. I found that knockdown of Snail1 by siRNA 
significantly increased ethanol-induced apoptosis as compared to the NCCs 
transfected with control siRNA, confirming that down-regulation of Snail1 can 
induce apoptosis in NCCs. Down-regulation of Snail1 by siRNA also significantly 
diminished the protective effects of SFN on ethanol-induced apoptosis in NCCs 
(Figure 5.7B), indicating that SFN can attenuate ethanol-induced apoptosis by 
modulating the expression of Snail1, further supporting our hypothesis. 
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Figure 5. 7. SFN diminished ethanol-induced apoptosis in NCCs through the up-
regulation of Snail1. (A) NCCs were exposed to 1 µM SFN for 24 h, followed by 
concurrent exposure to 1 µM SFN and 50 mM ethanol for 24 h. Apoptosis was 
determined by the analysis of caspase-3 cleavage using Western blot (B) NCCs 
transfected with control or Snail1 siRNA was determined by Western blot. 
Apoptosis was determined by flow cytometry with Annexin V-FITC apoptosis 
detection kit. Data are expressed as fold change over control (A) or percentage of 
all cells (B) and represent the mean ± SEM of three separated experiments. 
*p<0.05, **p<0.01. 
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8. The knockdown of KDM5A significantly diminished the ethanol-
induced inhibition of H3K4me3 expression and reduction of H3K4me3 
enrichment at Snail1 promoters.  
           To further explore the effect of KDM5A on the ethanol-induced reduction of 
H3K4me3 enrichment at Snail1 promoter, the expression of H3K4me3 and the 
H3K4me3 enrichment at Snail1 promoter in NCCs transfected with control or 
KDM5A siRNA were analyzed. The results indicated that knockdown of KDM5A by 
siRNA significantly reduced the ethanol-induced inhibition of H3K4me3 expression 
in NCCs (Figure 5.9A). In addition, the ChIP-qPCR analysis revealed that NCCs 
transfected with siKDM5A significantly diminished ethanol-induced reduction of 
H3K4me3 at Snail1 promoter regions (Figure 5.9B).  
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Figure 5. 8. Down-regulation of KDM5A significantly diminished ethanol-induced 
inhibition of H3K4me3 expression and reduction of H3K4me3 enrichment at the 
Snail1 promoter regions in NCCs. NCCs transfected with control siRNA, or 
KDM5A-siRNA were treated with or without 50 mM ethanol for 24 hours. (A). The 
nuclear protein was extracted and the expression of H3K4me3 and histone H3 
were determined by western blotting. The KDM5A expression at the protein level 
was determined by western blotting. (B). H3K4me3 enrichment at corresponding 
sites (P1-P5) was determined by ChIP-qPCR. Data as fold change over control (A) 
of percentage of input (B) and represent the mean ± SEM of three separated 
experiments. *p < 0.05, **p< 0.01. 
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9. Down-regulation of KDM5A diminished ethanol-induced inhibition of 
EMT in NCCs.  
           To determine whether ethanol-induced up-regulation of KDM5A contributes 
to ethanol-induced inhibition of EMT, the effects of down-regulation of KDM5A on 
the expression of Snail1 were determined in ethanol-exposed NCCs. As expected, 
knockdown of KDM5A prevented the ethanol-induced down-regulation of Snail1 
(Figure 5.9A). Snail1 is a key transcriptional factor that promotes EMT by targeting 
EMT repressing maker E-cadherin96, 104, 106, 107. I further determine the mRNA 
expression of E-cadherin in NCCs transfected with control or KDM5A siRNA. As 
observed in Figure 5.9B, NCCs transfected with siKDM5A significantly reduced 
ethanol-induced increase of E-cadherin expression. To further determine whether 
the downregulation of KDM5A can restore ethanol-induced inhibition of EMT in 
NCCs, both EMT promoting marker E-cadherin and repressing marker vimentin 
were analyzed in NCCs transfected with control or KDM5A siRNA. As shown in 
Figure 5.9C, ethanol treatment significantly inhibits EMT in NCCs, as indicated by 
the increased protein expression of E-cadherin and a decreased protein 
expression vimentin. Downregulation of KDM5A significantly reduced ethanol-
induced changes in the expression of E-cadherin and vimentin. These results 
clearly demonstrated that knockdown of KDM5A significantly prevented ethanol-
induced inhibition of EMT in NCCs. 
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Figure 5. 9. Down-regulation of KDM5A diminished ethanol-induced inhibition of 
EMT in NCCs. NCCs transfected with control-siRNA or KDM5A-siRNA were 
treated with or without 50 mM ethanol for 24 hours. The mRNA expression of 
Snail1 (A) and E-cadherin (B) were determined by quantitative RT-qPCR. The 
protein expression of E-cadherin and vimentin were determined by western blotting 
(C). Data are expressed as fold change over control and represent the mean ± 
SEM of three separated experiments. *p < 0.05, **p< 0.01.  
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10.  The knockdown of KDM5A significantly decreased ethanol-induced   
apoptosis in NCCs and zebrafish embryos.  
            To determine whether the downregulation of KDM5A can prevent ethanol-
induced apoptosis, apoptosis was analyzed by caspase-3 activation and Annexin 
V staining in control and ethanol-exposed NCCs transfected with control or KDM5A 
siRNA. As shown in Figure 5.10A, exposure of NCCs to ethanol resulted in a 
significant increase in caspase-3 activation, knockdown of KDM5A by siRNA 
significantly decreased caspase-3 activation in NCCs exposed to ethanol. The flow 
cytometry results indicated that the number of apoptotic cells was dramatically 
decreased in KDM5A deficient NCCs exposed to ethanol, as compared with the 
ethanol-treated group (Figure 5.10B). To determine whether knockdown of 
KDM5A prevented ethanol-induced apoptosis in vivo, zebrafish embryos were 
microinjected with control or KDM5A morpholino at one cell-stage, and treated with 
or without ethanol for 24 hours. TUNEL staining was used to determine the 
apoptotic cells in the whole zebrafish embryos. As shown in Figure 5.10C, ethanol 
treatment resulted in excessive apoptotic cells in the forebrain, middle brain and 
hindbrain. Knockdown of KDM5A by microinjection with KDM5A morpholino 
attenuate ethanol-induced apoptosis in zebrafish embryos. 
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Figure 5. 10. The knockdown of KDM5A significantly decreased ethanol-induced 
apoptosis in NCCs and zebrafish embryos. NCCs transfected with control, or 
KDM5A siRNA were treated with or without 50 mM ethanol for 24 hours. Apoptosis 
was determined by the analysis of caspase-3 cleavage by western blotting (A) or 
flow cytometry with Annexin V-FITC apoptosis detection kit (B).  Zebrafish embryos 
were microinjected with control or KDM5A morpholino at the one-cell stage and 
treated with or without for 24 hours. Apoptosis was analyzed by whole-mount 
TUNEL staining of the zebrafish embryos from control and treated groups. Scale 
bar: 200 µm. Data are expressed as fold change over control (A) and percentage 
of whole cells (B) and represent the mean ± SEM of three separated experiments. 
*p<0.05, **p<0.01. 
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D.  Discussion 
      Apoptosis in NCCs is one of the major mechanisms underlying the 
pathogenesis of FASD. Recent studies have shown that SFN can epigenetically 
restore the expression of Bcl-2 and attenuate ethanol-induced apoptosis by 
enhancing histone acetylation at the Bcl-2 promoter18. The results from this study 
have shown that treatment with SFN significantly prevented ethanol-induced 
changes in the expression of E-cadherin and vimentin, and restored EMT in NCCs. 
I also found that ethanol exposure significantly reduced the levels of H3K4me3 at 
the promoter regions of Snail1. In addition, SFN treatment diminished the ethanol-
induced reduction of H3K4me3 at the promoter regions of the Snail1 gene, 
restored Snail1 gene expression and EMT. I have also found that the expression 
of KDM5A was increased by ethanol, which can be diminished by SFN treatment. 
Downregulation of KDM5A by siRNA significantly reduced ed ethanol-induced 
inhibition of H3K4me3 expression as well as the H3K4me3 enrichment at the 
promoter regions of the Snail1 gene. In addition, the Snail1 expression and EMT 
were restored in KDM5A deficient NCCs exposed to ethanol. Moreover, 
knockdown of KDM5A prevented ethanol-induced apoptosis in NCCs and 
zebrafish embryos.  
        It is well known that the EMT is a process that can inhibit apoptosis, promote 
the proliferation, migration and metastasis of tumor cells100, 191, 205, 206. Study has 
shown that EMT conferred resistance to UV-induced apoptosis in murine 
mammary epithelial cell lines102. It has also been shown that α-mangostin can 
inhibit EMT and induce apoptosis in an osteosarcoma cell line. EMT is also critical 
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for the development of tissues and organs in the embryos93, 95, 97, and plays a 
crucial role in the regulation of the migration of NCCs10, 91, 207. However, the 
involvement of EMT in the ethanol-induced apoptosis in NCCs is currently unclear. 
I have demonstrated that ethanol treatment significantly inhibited EMT in NCCs, 
as indicated by an increased expression of E-cadherin and a decreased 
expression of vimentin, and induced apoptosis in NCCs. Treatment with SFN 
significantly diminished ed ethanol-induced changes in the expression of E-
cadherin and vimentin, restored EMT, and reduced apoptosis in NCCs. These 
results suggest that inhibition of EMT contributes to ethanol-induced apoptosis in 
NCCs.   
       Snail1 is a member of the Snail superfamily of zinc-finger transcription factors 
that are involved in cell survival and differentiation104, 105, 208. Snail1 has a crucial 
role in the regulation of EMT through its repression of E-cadherin, an adhesion 
molecule mostly expressed in the surface of epithelial-like cells51, 98, 192, 208, 209. 
Studies have shown that ethanol treatment decreased the expression of Snail1 
mRNA and inhibited EMT in B16-BL6 melanoma cells210 and that Snail1 repressed 
TGF- β-induced apoptosis in hepatocytes by triggering EMT205. Ethanol exposure 
was also found to be able to down-regulate the Snail2 in NCCs of chick embryos 
211. Consistent with these findings, I found that ethanol exposure resulted in a 
significant reduction in the expression of Snail1, accompanied by a dramatic 
increase in the expression of E-cadherin in NCCs. These results suggest that 
ethanol exposure can inhibit EMT in NCCs by down-regulating Snail1, leading to 
the up-regulation of E-cadherin. 
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        The expression of Snail1 can be regulated by a variety of mechanisms. 
Studies have shown that NF-kB, HIF-1a, SMAD, STAT3, and Gli1 can directly 
interact with the Snail1 promoter and regulate Snail1 at the transcriptional level 192, 
206, 208. The expression of Snail1 can also be regulated epigenetically. In eukaryotic 
cells, epigenetic regulation of gene expression mainly comprises DNA modification 
and histone modification51, 72, 209. It has been reported that HDAC inhibitor valproic 
acid (VPA) elevated histone acetylation to transcriptionally activate Snail1 gene 
expression and promote EMT in colorectal cancer cells108. HDAC inhibitors, 
Trichostatin A (TSA) and Suberoylanilide hydroxamic acid (SAHA) also induced 
EMT in prostate cancer cells212. While acetylation of histone lysine residues can 
increase genome accessibility, thus promoting gene transcription, methylation at 
lysine residues can have either activating or repressing effects on gene 
transcription. It is well-known that trimethylation of histone 3 at lysine 27 
(H3K27me3) is associated with transcription repression while trimethylation of 
histone 3 at lysine 4 (H3K4me3) is associated with transcription activation213. 
H3K4me3 is highly enriched at active promoters near transcription start sites and 
is widely used as a histone mark to identify active gene promoters214. Interestingly, 
methylation of H3K4 is a kind of modifications that is associated with gene 
activation, implicated in neurodevelopment disorder194, 198, 199. In this study, I found 
that ethanol exposure resulted in a significant decrease in the levels of H3K4me3 
in NCCs and a significant reduction of H3K4me3 enrichment at the promoter 
regions of Snail1. Co-treatment with SFN and ethanol significantly increased the 
H3K4me3 expression in NCCs and diminished the ethanol-induced reduction of 
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H3K4me3 enrichment at the promoter regions of Snail1. These results indicate that 
the ethanol can induce apoptosis in NCCs by inhibiting EMT through epigenetically 
down-regulating the expression of Snail1 which can be prevented by SFN. 
       One of the key histone demethylases that remove the activating mark of 
H3K4me3 is KDM5A. KDM5A, also known as retinoblastoma binding protein 2 
(RBP2), was associated with various cancer215-217 and neurodevelopment 
disorder198, 199.  It has been shown that various HDAC inhibitors manifested a high 
inhibitory activity for KDMs200. Consistent with this finding, I found that SFN, an 
HDAC inhibitor, significantly decrease KDM5A in ethanol-exposed hNCCs. 
Furthermore, substantial studies have established that KDM5A can repress gene 
expression through maintaining the low levels of H3K4me3 at gene promoter80, 218-
220. The present study indicated that ethanol-induced overexpression of KDM5A 
subsequently downregulated the H3K4me3 expression. In addition, knockdown of 
KDM5A by siRNA significantly increased H3K4me3 expression in ethanol-exposed 
NCCs. These results indicate that H3K4me3 is the direct target of KDM5A in NCCs. 
In addition, the down-regulation of KDM5A by siRNA significantly reduced ethanol-
induced reduction of H3K4me3 enrichment at Snail1 promoter and subsequently 
restored Snail1 expression in NCCs. Furthermore, Snail1 is well recognized as a 
direct repressor of E-cadherin and can promote EMT process96, 104, 106, 107. In the 
present study, I found that the down-regulation of KDM5A by siRNA diminished 
ethanol-induced increase in the expression of E-cadherin. These results indicated 
that the up-regulation of KDM5A represses the expression of Snail1 through the 
demethylation of H3K4me3 at Snail1 promoter, contributing to the inhibition of EMT 
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in ethanol-exposed NCCs. The down-regulation of KDM5A by siRNA also 
significantly protected the NCCs from ethanol-induced apoptosis. Additionally, 
knockdown of KDM5A by microinjecting with morpholino KDM5A dramatically 
decreased ethanol-induced apoptotic cell death in the craniofacial position of 
zebrafish embryos. These results are consistent with the Klose’s work that show 
that RBP2 (KDM5A) knockout mice displayed decreased apoptosis in 
hematopoietic stem cells80.  
       In summary, the present study indicated that ethanol exposure can inhibit EMT 
through the down-regulation of Snail1 by decreasing H3K4me3 enrichment at the 
promoter regions of Snail1 and increase apoptosis in NCCs. SFN treatment can 
diminish the ethanol-induced reduction in the H3K4me3 enrichment at the 
promoter regions of Snail1, restore mRNA expression of Snail1 and EMT in NCCs 
exposed to ethanol. Ethanol exposure also significantly up-regulated KDM5A, 
which can be diminished by co-treatment with SFN. Furthermore, knockdown 
KDM5A by siRNA increased the expression of H3K4me3 and H3K4me3 
enrichment at the Snail1 promoter. Down-regulation of KDM5A also restored 
Snail1 expression and EMT process and prevented apoptosis in ethanol-exposed 
NCCs. These results demonstrate that the disruption of EMT contributes to 
ethanol-induced apoptosis in NCCs and that SFN can prevent ethanol-induced 
apoptosis by restoring EMT through epigenetically regulating the expression of 
EMT-related genes, suggesting that elucidation of Snail1’s role in EMT and 
ethanol-induced apoptosis in NCCs may provide critical insight into the 
pathogenesis of FASD.
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CHAPTER VI 
 
MATERNAL DIETARY ADMINISTRATION OF BROCCOLI SPROUT EXTRACT 
DIMINISHED ETHANOL-INDUCED APOPTOSIS AND TERATOGENESIS IN 
MOUSE EMBRYOS BY EPIGENETICALLY MODULATING ANTI-APOPTOTIC 
GENES 
 Introduction 
      The previous work utilizing animal models has shown that exposure to ethanol 
during the early stage of embryogenesis can result in craniofacial abnormalities 
that are characteristic of fetal alcohol syndrome disorder (FASD). Specifically, 
ethanol exposure could induce small head circumference, flat midface, short nose, 
indistinct philtrum, thin upper lip, short palpebral fissures and other defects221, 222. 
Studies by Kotch and Sulik, as well as Dunty et al. in mice and Cartwright and 
Smith in chicks have revealed the sensitivity of the craniofacial region and 
developing brain to the deleterious effects of ethanol. These studies have shown 
that ethanol exposure during gastrulation and/or neurulation resulted in excessive 
apoptosis in neuroepithelium as well as other cell populations, including neural 
crest cells and ectodermal placodes14, 130, 131, 156. The results of a whole embryo 
culture study by Van Maele-Fabry et al. also support the conclusion that neural 
crest cells and placodes are targets of ethanol’s teratogenesis223. 
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Furthermore, study by Debelak and Su et al. has shown that the severity of 
ethanol-induced neural crest apoptosis and craniofacial dysmorphology is 
influenced by genetics in an avian model of FASD224, 225. Taken together, ethanol-
induced apoptosis contributes to the dysmorphology of the craniofacial region and 
the developing brain in the FASD model. Therefore, preventing ethanol-induced 
apoptosis could be a promising therapeutic strategy for the prevention of FASD. 
Studies from our laboratory and others have shown that multiple signaling 
pathways are involved in ethanol-induced apoptosis, including Sonic Hedgehog 
(SHH) signaling226, p53 pathways227, epithelial-mesenchymal transition (EMT)133 
and Bcl2 family228. For instance, SHH is a potent cell survival factor and disruption 
in SHH signaling by ethanol may cause massive apoptosis in neural crest cells 
and neuroepithelial cells226, 229, 230. Studies have also shown that ethanol exposure 
caused oxidative stress, eventually triggering the apoptotic pathway17, 231, 232. The 
recent study from our laboratory has demonstrated that ethanol exposure 
significantly decreased the expression of Snail1, one of the major EMT 
transcriptional factors, and increased apoptosis in neural crest cells133. We have 
also shown that ethanol can induce apoptosis through epigenetically 
downregulating the anti-apoptotic gene, Bcl2, and subsequently lead to massive 
apoptosis in mouse embryos18. These results demonstrate that anti-apoptotic 
genes are crucial in regulating apoptosis and ethanol’s teratogenesis. The 
previous study in our laboratory indicated that sulforaphane (SFN), found 
abundantly in broccoli and cruciferous vegetables, can reduce ethanol-induced 
apoptosis in both neural crest cells and mouse embryos17, 18, 133. More interestingly, 
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studies have shown that SFN can epigenetically regulate apoptosis by acting as 
an inhibitor of histone deacetylase (HDAC) and DNA methyltransferase (DNMT), 
two key enzymes involved in histone deacetylation and DNA methylation18, 133. 
Recently, broccoli sprout extract (BSE), has gained a lot of attention because it 
can specifically deliver a reproducible and standardized dose of glucoraphanin, a 
precursor of SFN. Glucoraphanin is available in commonly consumed cruciferous 
vegetables. BSE is considered to have low toxicity, and its administration in 
humans is well tolerated120-122. It was reported that dietary consumption of BSE 
can reduce the risk of several types of cancers, including prostate breast, lung and 
colorectal cancers119, 123, 124. For instance, consumption of  BSE inhibits HDAC 
activity in peripheral blood mononuclear cells, accompanied by the induction of 
acetylation of histone H3 and H4 in human subjects125. Moreover, evidence by 
Hashimoto et al. has shown that dietary intake of SFN-rich BSE was capable of 
preventing PCP-induced cognitive deficits and oxidative stress in mice126. 
Furthermore, SFN-rich BSE significantly improves social interaction, abnormal 
behavior and verbal communication in young men with autism spectrum 
disorders120.  
       For the present investigation, I tested the hypothesis that maternal dietary 
administration of BSE can prevent ethanol-induced apoptosis and teratogenesis 
through epigenetically regulating the anti-apoptotic genes. Through using the in 
vivo oral take FASD model system, I found that the anti-apoptotic genes were 
hypermethylated by maternal consumption of ethanol, which can be diminished by 
maternal dietary administration of BSE. Subsequently, maternal dietary BSE 
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diminished ethanol-induced down-regulation of the anti-apoptotic genes. Moreover, 
BSE consumption prevented ethanol-induced apoptosis in mouse embryos. 
Furthermore, I found that maternal consumption of BSE conferred in vivo 
protection against ethanol-induced teratogenesis, including the anterior tube 
defects and ocular abnormalities in mouse embryos. These results demonstrate 
that epigenetic modulation of the anti-apoptotic genes by maternal dietary SFN-
rich BSE represents a novel therapeutic strategy for the prevention of ethanol-
induced teratogenesis. 
 Experimental Procedures 
1. Animals and treatments 
           Animals were maintenance, treated with ethanol and BSE, as described in 
Chapter II Section B.1 and in the Experimental scheme 6.1. 
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Experimental scheme 6. 1. FASD mouse model and experimental procedure. Mice 
received ethanol-containing or control liquid diet for an initial 14 days then moved 
to the lab chow for mating. 4.8% ethanol liquid diet with or without 3 mg BSE/mL 
diet was re-introduced to the experimental groups of pregnant mice on GD 7.0 and 
GD 8.0. Pregnant mice will be killed on GD 9.0 or GD 14.0 for further analysis (see 
Experimental procedure).   
2. Methylated specific PCR (MSP) 
           Pregnant mice were sacrificed on GD 9 and the whole brain was dissected 
from the mouse embryos from control and experimental groups. The genome DNA 
was isolated from the whole brain of embryos from control and experimental 
groups, and DNA methylation at the promoters of the anti-apoptotic genes was 
determined as described in Chapter II, C. 6. 
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3. Dysmorphology assessment 
           Pregnant mice were sacrificed on GD 9, and the embryos were dissected 
and kept in ice-cold PBS. The embryos were then photographed under a 
microscope (SZX16, Olympus, USA). Ocular dysmorphology was assessed at GD 
14. The pregnant mice were sacrificed on GD 14, and the embryos were dissected 
from the uterus. The eyes were photographed under a microscope (SZX16, 
Olympus, USA).  
4. TUNEL Staining 
           Analysis of apoptosis in mouse embryos was performed by using a TMR 
Red in Situ Detection Kit (Millipore, Temecula, CA), following the manufacturer’s 
protocol. Briefly, the mouse embryos were fixed with 4% paraformaldehyde 
overnight, then dehydrated in 100% methanol at -20 ºC for at least 2 hours, 
following by rehydrating the embryos through a series of methanol dilutions. Then 
the embryos were permeabilized with proteinase K at room temperature for 8 min 
following with 0.1% Triton-100 in 0.1% sodium citrate treatment at room 
temperature for an additional 15 min. After that, the embryos were pre-fixed with 
4% paraformaldehyde for 20 min and then stained with the TUNEL reaction 
mixture at 37 ºC for 1 hour. Following the staining, the mouse embryos were 
visualized in the green channel of a fluorescent microscope (SZX16, Olympus, 
USA).   
5. Quantitative real-time PCR 
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           mRNA expression of AKT1, BIRC5, BCl2, and NAIP were determined by 
quantitative real-time PCR, as described in Chapter II, Section C.2. 
6.  Western Blot 
           The protein level of AKT1, BIRC5, BCl2, NAIP, and Cleaved caspase-3, 
were determined by western blot, as described in Chapter II, Section C.3.  
7.  Statistical analysis 
 Statistical analysis was performed, as described in Chapter II, C. 8. 
C. Results 
 Maternal dietary BSE administration significantly reduced ethanol-
induced hypermethylation at the promoters of the selected anti-
apoptotic genes in mouse embryos.  
           To determine whether maternal dietary BSE can reduce ethanol-induced  
hypermethylation at the promoter regions of the anti-apoptotic genes in mouse 
embryos exposed to ethanol, the whole brain was dissected from GD 9.0 mouse 
embryos, and the methylation levels at the promoter regions of the anti-apoptotic 
genes were analyzed. As shown in Figure 6.1, maternal dietary BSE significantly 
diminished ethanol-induced hypermethylation at the promoters of AKT1, Bcl2 and 
NAIP in mouse embryos. 
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Figure 6. 1. Maternal dietary BSE significantly diminished ethanol-induced 
hypermethylation at the promoters of AKT1, Bcl2 and NAIP in mouse embryos. 
Control and treated mice were sacrificed at GD 9.0. The whole brain was dissected 
from the embryos and the genome was isolated. (A) Schematic illustration of CpG 
sites and CpG island at the promoters of the anti-apoptotic genes. (B) DNA 
methylation status at the CpG island of the selected anti-apoptotic genes was 
determined by using MSP. Data are expressed fold change over control and 
represent the mean ± SEM of three separated experiments. *p < 0.05, **p< 0.01, 
***p<0.001. 
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 Maternal dietary BSE reduced the ethanol-induced down-regulation of 
the selected anti-apoptotic genes in mouse embryos 
           DNA methylation is the most extensively studied epigenetic modification, 
which has an important role in the regulation of gene expression. DNA 
hypermethylation on CpG island compacts the chromatin, silencing the gene 
expression. Conversely, when DNA methylation is lowered, the chromatin is 
allowed to open and subsequently leads to gene activation233, 234. To determine 
whether the diminished hypermethylation at the promoter region of the anti-
apoptotic genes induced by maternal dietary BSE in ethanol-exposed mouse 
embryos can reduce ethanol-induced down-regulation of the selected anti-
apoptotic genes, the expression of the anti-apoptotic genes was determined by 
qRT-PCR and western blot. As expected, ethanol treatment alone robustly 
decreased the mRNA expression of AKT1, Bcl2 and NAIP. BSE administration 
significantly diminished the ethanol-induced down-regulation of these anti-
apoptotic genes (Figure 6.2A). Moreover, maternal dietary BSE also significantly 
diminished ethanol-induced decrease in the protein expression of AKT1, Bcl2 and 
NAIP in mouse embryos (Figure 6.2B). These results demonstrate that maternal 
dietary BSE can prevent ethanol-induced down-regulation of the anti-apoptotic 
genes. 
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Figure 6. 2. Maternal dietary BSE prevented ethanol-induced down-regulation of 
anti-apoptotic genes in mouse embryos. The control and treated mice were 
sacrificed at GD 9.0, and then the whole brain was dissected from the mouse 
embryos. The mRNA (A) and protein (B) expression of the anti-apoptotic genes 
were analyzed by quantitative RT-PCR and Western blot, respectively. Data are 
expressed as fold change over control and represent the mean ± SEM of three 
separated experiments. *p < 0.05, **p< 0.01, ***p<0.001. 
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 Maternal dietary BSE protected against ethanol-induced apoptosis in 
mouse embryos 
           To determine whether maternal dietary BSE can prevent ethanol-induced 
apoptosis, apoptosis was examined by analysis of caspase-3 activation and whole-
mount TENEL staining in control and treated mouse embryos. As shown in Figure 
6.3A, ethanol exposure resulted in a significant increase in caspase-3 activation, 
indicating that ethanol exposure increased apoptosis in mouse embryos. BSE 
administration significantly reduced caspase-3 activation in mouse embryos 
exposed to ethanol. Moreover, the apoptotic cells were evaluated  by whole-mount 
TUNEL staining of control and treated GD 9.0 mouse embryos. As compared to 
control group, ethanol-exposed mouse embryos displayed excessive apoptosis in 
the hindbrain with staining most intensely in the hindbrain alar plate, additional 
locations of excessive apoptosis were observed in the forebrain, middle brain 
(white arrow), trigeminal ganglion (V) as well as first arch (I). BSE administration 
significantly attenuated ethanol-induced excessive apoptosis in mouse embryos 
(Figure 6.3B). These results demonstrate that maternal dietary BSE can prevent 
ethanol-induced apoptosis in mouse embryos. 
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Figure 6. 3. Maternal dietary BSE protects against ethanol-induced apoptosis in 
mouse embryos. The control and treated mice were sacrificed at GD 9.0, and the 
mouse embryos were dissected. (A)  Apoptosis was determined by the analysis of 
caspase-3 cleavage using Western blot. (B) The whole-mount TUNEL staining of 
mouse embryos from control and treated groups was visualized under a 
fluorescence microscope. Data are expressed as fold change over control and 
represent the mean ± SEM of three separated experiments. **p< 0.01 ***p<0.001. 
I=first arch; V=trigeminal ganglion. 
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 Maternal dietary BSE confers in vivo protection against ethanol-
induced teratogenesis in mouse embryos. 
           To determine whether dietary consumption of BSE can prevent ethanol-
induced teratogenesis, the morphology of the control and treated mouse embryos 
was assessed on GD 9.0. As compared with control groups, ethanol-exposed 
mouse embryos displayed a marked decrease in the size of the forebrain, midbrain 
and hindbrain, BSE administration reduced ethanol-induced brain growth 
retardation on GD 9.0. Moreover, the size of the first branchial arches was reduced 
in the ethanol-treated group, as compared with the control group. BSE treatment 
prevented the ethanol-induced decrease in the size of the first arches. (Figure 
6.4A). Additionally, ethanol exposure alone significantly decreased the number of 
live embryos, somite number and crown-rump length in GD 9.0 mouse embryos. 
Moreover, ethanol treatment also significantly increased the incidence of neural 
tube defects in mouse embryos. BSE administration significantly ameliorated 
ethanol-induced growth retardation and abnormalities in GD 9.0 mouse embryos. 
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Figure 6. 4. BSE administration confers in vivo protection against ethanol-induced 
teratogenesis. Control and treated groups were sacrificed at GD 9.0 and the 
mouse embryos were dissected. (A) Illustrated are the mouse embryos of control 
and treated groups showing the ethanol-induced growth retardation and neural 
tube defects and the protective effects of BSE on the ethanol-induced growth 
retardation and neural tube defects. (B) Statistic analysis of the number of live 
embryos somite number, crown-rump length and neural tube defects in GD 9.0 
mouse embryos. Data are expressed as mean ± SEM. *p < 0.05, **p< 0.01. 
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 Maternal dietary administration of BSE prevented ethanol-induced 
ocular abnormalities in mouse embryos.  
           To determine whether BSE adminstration can prevent ethanol-induced 
ocular abnormalities, the control and treated mice were sacrifiered at GD 14, and 
the ocular abnormalities were examined. As shown in Figure 6.5A, ethanol 
exposure significantly increased the incidence of abnormalities in the right eyes. 
Additionally, using the rating scale described in Figure 6.5B, I found that ethanol 
administration increased the severity of ocular defects as compared with the 
control group, with 24% of the right eyes in the ethanol group being mildly affected 
(a rating of 2), whereas 6% of the eyes were both slightly microphthalmic and had 
abnormally shaped pupils (a rating of 3), 3% of the eyes were moderately 
microphthalmic (a rating of 4), and 3% were severely microphthamic (a rating of 
5). Concurrent exposure of the pregnant mice to BSE and ethanol resulted in a 
lower incidence and severity of ocular abnormalities compared with ethanol alone 
group. The incidence of eye defects in the group treated with both ethanol andBSE  
was reduced by 21% in the right eyes as compared with that in ethanol alone group. 
There were no fetuses with the moderate-severe (rating of 4) or the most severe 
(rating of 5)  ocular defects in the group treated with both ethanol and BSE (Figure 
6.5C). 
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Figure 6. 5. Maternal dietary administration of BSE prevented ethanol-induced 
ocular abnormalities in mouse embryos. The control and experimental mice were 
sacrificed at GD 14.0 and the mouse embryos were dissected for assessment. (A) 
Ocular dysmorphology was visualized under a microscope. (B) Range of ocular 
defects. The eyes were rated according to the following categories: normal eye 
(rating of 1) (1); slightly abnormal pupil shape (rating of 2) (2); mild microphthalmia 
and slightly abnormal pupil shape (rating of 3) (3); moderate microphthalmia (rating 
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of 4) (4); and severe microphthalmia (rating of 5) (5). (C) Incidence and severity of 
ocular defects. Ethanol exposure resulted in significant increases in both the 
incidence and severity of ocular abnormalities in both the left (*) and the right eyes 
(#). Concurrent exposure to ethanol and BSE resulted in a lower incidence of 
ocular defects in both the left (@) and right (+) eyes compared with ethanol alone 
groups. 
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D.  Discussion 
      Apoptosis plays an important role in ethanol-induced teratogenesis. Recent 
studies have shown that SFN can attenuate ethanol-induced apoptosis through 
epigenetically up-regulating the anti-apoptotic genes, Bcl2 andSnail118, 133 . In this 
study, I have found that maternal consumption of BSE significantly reduced 
ethanol-induced down-regulations of the anti-apoptotic genes, AKT1, Bcl-2 and 
NAIP, in mouse embryos through diminishing ethanol-induced hypermethylation 
at the promoter regions of these anti-apoptotic genes. I have also found that BSE 
administration diminished ethanol-induced apoptosis in mouse embryos, as 
indicated by the reduction of cleaved caspase-3 expression. TUNEL staining also 
revealed that the apoptosis in the brain and first branchial arches was significantly 
reduced in ethanol and BSE co-treatment group as compared with ethanol alone 
group. Maternal dietary BSE also significantly ameliorated ethanol-induced growth 
retardation, neural tube defects and ocular abnormalities in mouse embryos.  
       SFN can modulate gene expression by inhibition of HDAC and DNMT, two 
enzymes associated with histone deacetylation and DNA methylation. The 
previous study in our lab has demonstrated that SFN increased acetyl-histone H3 
binding to the Bcl-2 promoter, reduced ethanol-induced apoptosis in both neural 
crest cells and mouse embryos18. Moreover, study has also indicated that SFN 
inhibited HDAC activity in human colon235 and prostate cancer cell liness and 
resulted in an increase in global and local histone acetylation status on the 
promoter region of apoptosis-related genes244. In addition to modulating HDACs 
and histone acetylation, SFN can also regulate DNA methylation by acting as an 
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inhibitor of DNMTs. It was reported that SFN suppressed DNA methylation in the 
hTERT promoter, leading to transcriptional repression in breast cancer cells236. 
Another study by Anna et al. has shown that SFN significantly decreased 
enzymatic activity of DNMTs and decreased methylation on cyclin D2 promoter 
regions in prostate cancer cells237. SFN is a compound produced by the conversion 
of glucoraphanin in the presence of the myrosinase enzyme238. Increased amounts 
of glucoraphanin can enhance SFN production in broccoli or broccoli sprouts. BSE 
contains up to 50 times higher concentrations of glucoraphanin than mature 
broccoli239. Consumption of BSE has been found to significantly increase 
isothiocyanate levels in human plasma. Additionally, it has also been 
demonstrated that SFN can cross the placenta during maternal dietary 
supplementation of BSE between GD 9.0 to GD 19.0 in mice. In human subjects, 
a single dose of 68 g BSE significantly inhibited HDAC activity in peripheral blood 
mononuclear cells 3 hours following treatment, with the increased induction of 
acetylation of histones H3 and H4125. However, the dietary BSE on DNA 
methylation is not well known. In the present study, I found that maternal dietary 
BSE reduced the ethanol-induced hypermethylation at the promoter regions of the 
anti-apoptotic genes, including AKT1, Bcl-2, and NAIP, in mouse embryos 
exposed to ethanol. In addition, SFN-rich BSE-mediated reduction of 
hypermethylation at the promoter regions of these anti-apoptotic genes 
significantly diminished ethanol-induced down-regulation of these genes in mouse 
embryos. Maternal dietary BSE also prevented ethanol-induced apoptosis in 
mouse embryos exposed to ethanol, as evidenced by the reduction of caspase-3 
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activation and TUNEL staining in the group co-treated  with BSE and ethanol. 
These results are consistent with the study showing that SFN-enriched BSE 
inhibited neuronal apoptosis through inhibition of caspase-3 activation, leading to 
the neuroprotection against neurodegenerative disorders240.  
       Children with FASD display characteristic craniofacial anomalities, including 
short palpebral fissures, hypoplastic midface, deficient philtrum and long upper 
lip241, 242. Research by Dunty and Sulik has shown ethanol-induced apoptosis of 
specific progenitor cells leads to craniofacial deficits associated with FASD130. 
Consistent with these findings, I found that ethanol-exposed GD 9.0 mouse 
embryos displayed the short first branchial arch and reduced  brain size, which is 
also consistent with Scott and Sulik’s study that has shown that the size of the 
entire forebrain in ethanol exposed mouse embryos was significantly reduced243. 
Maternal dietary BSE significantly diminished the ethanol’s effects on the first 
branchial arch and brain size in mouse embryos. In addition, BSE administration 
significantly prevented the ethanol-induced reduction of the number of live 
embryos, somite number, and crown-rump length and ethanol-induced neural tube 
defects. These results demonstrate that maternal dietary administration of BSE 
can prevent ethanol-induced growth retardation and abnormalities in GD 9.0 
mouse embryos.    
       In the present study, ocular dysmorphology on GD 14.0 in mouse embryos 
was also selected as the key morphological endpoint for analysis. The ocular 
defects induced by ethanol were known to be involved in diminished global size 
and pupil abnormalities243. In this study, ethanol exposure caused 36% increase 
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in the ocular defects at the right eye and 16% increase in the left eye. This result 
is consistent with the previous studies usingan FASD model that has shown that 
the right eyes were affected at a markedly higher incidence than the left eyes231, 
243, 244. In ethanol and BSE co-treatment group, the defects of the right eye were 
reduced by 21% as compared with ethanol alone group. These results 
demonstrate that BSE can significantly diminish ethanol-induced ocular defects in 
mouse embryos. 
       In summary, this study indicated that the promoter region of the anti-apoptotic 
genes, includingAKT1, Bcl2 and NAIP, were hypermethylated in ethanol-exposed 
mouse embryos, which can be diminished by BSE administration. Maternal dietary 
BSE also diminished ethanol-induced down-regulation of the selected anti-
apoptotic genes and prevented ethanol-induced apoptosis in mouse embryos. In 
addition,  maternal dietary BSE significantly attenuated ethanol-induced growth 
retardation and neural tube defects in GD 9.0 mouse embryos and ethanol-induced 
ocular abnormalities in GD 14.0 mouse embryos. These findings provide insights 
into the epigenetic mechanisms involved in ethanol-induced apoptosis, growth 
retardation and teratogenesis in mouse embryos, suggesting that the epigenetic 
modulation of anti-apoptotic genes by using SFN-rich BSE might be a promising 
therapeutic strategy for the prevention of FASD.
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CHAPTER VII 
 
DISCUSSION AND CONCLUSIONS 
 
 Restatement of goals 
      The overall goal of the work described in this dissertation was to elucidate the 
epigenetic mechanisms by which SFN epigenetically regulates the anti-apoptotic 
gene expression and prevents ethanol-induced apoptosis and teratogenesis, as 
well as to develop new therapeutic approaches for the prevention of FASD. The 
experiments described in Chapter III were performed to determine whether SFN 
prevents the hNCCs from ethanol-induced apoptosis through altering the DNA 
methylation level at the promoter regions of the anti-apoptotic genes. The study 
described in Chapter IV tested the hypothesis that SFN can prevent ethanol-
induced apoptosis by modulating histone acetylation at the promoter region of the 
anti-apoptotic genes. The work described inn Chapter Vtested the hypothesis that 
SFN can protect against ethanol-induced apoptosis by restoring EMT through 
epigenetically modulating the expression of Snail1 in NCCs and that down-
regulation of KDM5A can prevent ethanol-induced apoptosis in NCCs and in 
zebrafish embryos.  The study described in Chapter VI tested  the hypothesis that 
maternal dietary administration of BSE can prevent ethanol-induced apoptosis and 
teratogenesis  through epigenetically regulating the anti-apoptotic genes. Taken 
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together, these studies provide novel information on the epigenetic mechanisms 
of ethanol-induced apoptosis and teratogenesis. These findings also suggest that 
epigenetic modulation of anti-apoptotic genes by SFN or BSE might be a promising 
strategy for the prevention of FASD.  
 Major findings of this dissertation 
 SFN protects against ethanol-induced apoptosis in hNCCs through 
diminishing ethanol-induced hypermethylation at the promoters of 
the anti-apoptotic genes.  
           Our studies described in Chapter III indicated that ethanol treatment can 
inhibit the expression of the anti-apoptotic genes, including AKT1, Bcl2, BIRC5, 
BIRC6, IGF1R, MCL1, NAIP and XIAP and that ethanol-induced repression of 
these anti-apoptotic genes can be prevented by SFN. We have also shown that 
ethanol exposure resulted in a significant increase in the DNMT activity and the 
expression of DNMT3a in hNCCs. SFN can significantly diminish ethanol-induced 
increases in DNMT activity and the expression of DNMT3a. We have also found 
that ethanol-induced up-regulation of DNMT3a and an increase in DNMT activity 
resulted in hypermethylation at the promoters of the selected anti-apoptotic genes 
in hNCCs and that SFN can diminish ethanol-induced hypermethylation at the 
promoters of anti-apoptotic genes by preventing ethanol-induced up-regulation of 
DNMT3a and increase in DNMT activity. In addition, the knockdown of DNMT3a 
or treatment with SFN significantly diminished ethanol-induced decreases in the 
mRNA and protein expression of NAIP and XIAP and prevented ethanol-induced 
apoptosis in hNCCs. The knockdown of DNMT3a also enhanced the effects of 
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SFN on the mRNA and protein expression of NAIP and XIAP and the protective 
effects of SFN on ethanol-induced apoptosis in hNCCs   
 SFN prevents hNCCs from ethanol-induced apoptosis by diminishing 
ethanol-induced reduction of histone acetylation at the promoters of 
the anti-apoptotic genes. 
           Our studies described in Chapter IV have indicated that ethanol exposure 
can increase HDAC activity and the expression of HDAC2 in hNCCs. SFN 
treatment significantly diminished ethanol-induced increase in HDAC activity and 
the up-regulation of HDAC2. We have also found that ethanol-induced increase in 
HDAC activity and up-regulation of HDAC2 resulted in the reduction of H3 
acetylation at the promoters of AKT1, BIRC6 and XIAP in hNCCs and that SFN 
diminished ethanol-induced reduction of H3 acetylation at the promoters of anti-
apoptotic genes by inhibiting HDAC activity and reducing ethanol-induced up-
regulation of HDAC2. In addition, SFN treatment or knockdown of HDAC2 
significantly diminished ethanol-induced decreases in the mRNA and protein 
expression of AKT1, BIRC6 and XIAP and prevented ethanol-induced apoptosis 
in hNCCs. The knockdown of HDAC2 also enhanced the effects of SFN on the 
mRNA and protein expression of AKT1, BIRC6 and XIAP and the protection 
against ethanol-induced apoptosis in hNCCs. 
 SFN protects against ethanol-induced apoptosis in NCCs and 
zebrafish embryos through modulating histone methylation and the 
expression of Snail 1 and restoring EMT.  
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           Our studies presented in Chapter V indicated that ethanol exposure can 
inhibit EMT through the down-regulation of Snail1 by decreasing H3K4me3 
enrichment at the promoter regions of Snail1 and increase apoptosis in NCCs. 
SFN treatment can diminish the ethanol-induced reduction in the H3K4me3 
enrichment at the promoter regions of Snail1, restoring mRNA expression of Snail1 
and EMT in NCCs exposed to ethanol. Ethanol exposure also significantly up-
regulated KDM5A, which can be diminished by co-treatment with SFN. 
Furthermore, knockdown KDM5A by siRNA increased the expression of H3K4me3 
and H3K4me3 enrichment at the Snail1 promoter. Down-regulation of KDM5A also 
restored Snail1 expression and EMT process and prevented apoptosis in ethanol-
exposed NCCs. These results demonstrate that the disruption of EMT contributes 
to ethanol-induced apoptosis in NCCs and that SFN can prevent ethanol-induced 
apoptosis by restoring EMT through epigenetically regulating the expression of 
EMT-related genes, suggesting that elucidation of Snail1’s role in EMT and 
ethanol-induced apoptosis in NCCs may provide critical insight into the 
pathogenesis of FASD. 
  Maternal dietary administration of SFN-rich BSE diminished ethanol-
induced apoptosis and teratogenesis in mouse embryos by 
epigenetically modulating anti-apoptotic genes.  
           The study described in Chapter VI indicated that the promoter region of the 
anti-apoptotic genes, including AKT1, Bcl2 and NAIP, were hypermethylated in 
ethanol-exposed mouse embryos, which can be diminished by BSE administration. 
Maternal dietary BSE also diminished ethanol-induced down-regulation of the 
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selected anti-apoptotic genes and prevented ethanol-induced apoptosis in mouse 
embryos. In addition, maternal dietary BSE significantly attenuated ethanol-
induced growth retardation and neural tube defects in GD 9.0 mouse embryos and 
ethanol-induced ocular abnormalities in GD 14.0 mouse embryos. These findings 
provide insight into the epigenetic mechanisms involved in ethanol-induced 
apoptosis, growth retardation and teratogenesis in mouse embryos, suggesting 
the epigenetic modulation of anti-apoptotic genes by using SFN-rich BSE might be 
a promising therapeutic strategy for the prevention of FASD. 
 Significance 
     FASD is among the most devastating consequences of the widespread use and 
abuse of alcohol. Prenatal ethanol exposure is considered to be the leading known 
non-genetic cause of mental retardation in the Western world. Growing evidence 
suggests a major contribution of apoptosis to ethanol-induced teratogenesis. This 
discovery suggests that therapeutic strategies directed against apoptosis are 
particularly valuable for the prevention of FASD. However, there is a fundamental 
gap in understanding how ethanol leads to apoptosis in embryos. The continued 
existence of this gap represents an important problem because, until it is filled, 
understanding of ethanol-induced apoptosis that leads to teratogenesis will remain 
largely incomprehensible.  
      Sulforaphane (SFN) is a chemical that is abundant in broccoli sprouts. It was 
recently discovered that SFN can regulate gene expression through epigenetic 
mechanisms, specifically by decreasing the activities of histone deacetylase and 
DNA methyltransferase. This supports the potential of dietary consumption of SFN 
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or SFN-rich broccoli sprouts to attenuate ethanol-induced apoptosis and confer in 
vivo protection against FASD through epigenetic regulation of the expression of 
anti-apoptotic genes. The objective of the work outlined in this study is to elucidate 
the epigenetic mechanisms by which ethanol induces apoptosis and teratogenesis 
and SFN regulates the anti-apoptotic gene expression and prevents ethanol-
induced apoptosis, and to develop a safe and effective regimen to diminish the 
incidence and severity of FASD using SFN or SFN-rich broccoli sprouts, a safe 
“nutraceutical”.  
      Our studies have demonstrated that SFN protects against ethanol-induced 
apoptosis in hNCCs through diminishing ethanol-induced hypermethylation at the 
promoters of the anti-apoptotic genes. SFN can also prevent hNCCs from ethanol-
induced apoptosis by diminishing ethanol-induced reduction of histone acetylation 
at the promoters of the anti-apoptotic genes. In addition, SFN protects against 
ethanol-induced apoptosis in NCCs and zebrafish embryos through modulating 
histone methylation and the expression of Snail1 and restoring EMT. Moreover, 
our studies have shown that maternal dietary administration of SFN-rich BSE 
diminished ethanol-induced apoptosis and teratogenesis in mouse embryos by 
epigenetically modulating anti-apoptotic genes. These results elucidate that 
epigenetic silencing of the anti-apoptotic genes through promoter 
hypermethylation and histone deacetylation is involved in ethanol-induced 
apoptosis and teratogenesis and that SFN can prevent ethanol-induced apoptosis 
and teratogenesis by preventing the aberrant epigenetic modifications.  
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      These findings are significant because a better understanding of the epigenetic 
mechanisms underlying ethanol-induced apoptosis is a necessary prerequisite to 
the development of strategies against ethanol-induced teratogenesis. The insights 
gained from this study help to define the role of SFN and broccoli sprout extract 
(BSE), a diet-derived epigenetic modulator, in the prevention of FASD. These 
results may establish dietary supplementation of broccoli sprout extract as a novel 
strategy for the prevention of human FASD, providing high translational relevance. 
Once such highly translatable strategies become available, important advances in 
the intervention of FASD could be expected. Regarding its impact on scientific 
advancement, the findings from this study not only advance the field of FASD 
research but also contribute to a broader understanding of the epigenetic 
regulation of apoptosis.    
 Strengths and limitations 
1. Strengths 
          There are a number of strengths of the research work presented in this 
dissertation. First, this is an innovative research work because it focuses on a 
novel approach, targeting epigenetic modulation directly involved in the apoptotic 
pathway, to prevent ethanol-induced apoptosis and teratogenesis. The theoretical 
concept described in the application is highly innovative because this is the first 
study attempting to prevent ethanol-induced apoptosis and teratogenesis 
specifically through the newly recognized actions of SFN or broccoli sprout extract 
as a dietary epigenetic regulator. Second, the approaches used in this research 
work are also innovative. These studies combine new and exciting discoveries in 
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epigenetics with state-of-the-art approaches, including quantitative real-time PCR, 
siRNA knockdown technology and ChIP-PCR approach. Third, this research 
uniquely integrates in vitro cell culture and in vivo mouse and zebrafish model 
systems to elucidate the mechanisms by which ethanol induces apoptosis and 
teratogenesis and SFN prevents ethanol-induced apoptosis and teratogenesis.  
Fourth, these studies combine epigenetic analysis and morphological 
characterization techniques to assess the role of SFN in modulating ethanol-
induced teratogenesis. Fifth, this is the first study using human neural crest cells 
(hNCCs) derived from human embryonic stem cells (hESCs) to elucidate the 
mechanisms underlying FASD. The use of hNCCs in this study is more closely 
mimic human responses in comparison to rodent cell lines and generates more 
relevant data representing human FASD, and therefore, has high translational 
potential for preventing FASD. Sixth, this research work represents the first attempt 
to prevent FASD through the use of bioactive compounds derived from a vegetable. 
The use of safe and effective epigenetic aberration-neutralizing dietary broccoli 
sprout extract is not only innovative but also has high translational potential for 
preventing FASD.  
2. Limitations 
          There are also several limitations of the research work presented in this 
dissertation.  One of the limitations is the siRNA technique that has been used to 
knock down the genes. It is well known that one of the major concerns for the 
siRNA approach is off-target effects.  For the siRNA experiments in Chapter III, IV 
and V, I have used the siRNA pool, a mixture of 4 siRNAs, to target the genes of 
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interest. Evidence has shown that the use of pooling of multiple siRNAs to target 
gene is an effective way to reduce off-target silencing because of competition 
among the siRNA in the pool. In addition,  since all members of the pool silence 
the same gene but have unique off-target signatures, this approach provides a 
selective reduction of off-target effects245, 246. However, while the pooling of 
multiple siRNAs can significantly reduce the off-target effects, it is impossible for 
this approach to completely address the concern with the off-target effects of the 
siRNA experiment.  To further address this concern, a second siRNA pool might 
be needed to validate the results from the studies using siRNA. In addition to the 
siRNA technique, methylated specific PCR (MSP) that has been used to determine 
the methylation at the promoter regions of the anti-apoptotic genes in Chapter III 
and Chapter VI is another limitation. Although MSP is a highly effective protocol to 
detect the DNA methylation status, it cannot quantify the exact methylated or 
unmethylated cytosine because the products the PCR amplification was examined 
on an electrophoresis gel. For this reason, follow-up studies are needed to confirm 
specific cytosines that were methylated by using pyrosequencing, a protocol that 
can accurately measure the degree of methylation at each CpGs with high 
quantitative resolution. 
 Future Directions 
      While the findings from the study s described in this dissertation provide new 
insight into the epigenetic mechanisms underlying ethanol-induced apoptosis and 
teratogenesis, this work also provides a foundation for our future studies, as 
outlined in this section.   
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 Elucidation of the molecular mechanisms underlying ethanol-induced 
increase in the activity of DNMTs and HDACs and up-regulation of 
DNMT3a, HDAC2 and KDM5A.   
     Our present study has shown that ethanol exposure can increase the activity of 
DNMTs and the expression of DNMT3a in hNCCs. Ethanol treatment also resulted 
in an increase in the activity of HDACs and the up-regulation of HDAC2.  In addition, 
exposure to ethanol significantly increased the expression of KDM5A in hNCCs.  
Ethanol-induced increases in the activities of DNMTs and HDACs and the up-
regulation of DNMT3a and HDAC2 contribute to the hypermethylation and 
reduction of the histone acetylation at the promoter regions of the anti-apoptotic 
genes, the repression of anti-apoptotic genes and apoptosis in hNCCs. Up-
regulation of KDM5A also resulted in the reduction of H3K4me3 enrichment at the 
promoters of Snail1, leading to the inhibition of EMT and apoptosis in hNCCs. 
However, the mechanisms by which ethanol-induced increases in the activities of 
DNMTs and HDACs, as well as the up-regulation of DNMT3a, HDAC2 and KDM5A 
are not clear and could be a very interesting future direction. Elucidation of the 
mechanisms underlying ethanol-induced increases in the activities of DNMTs and 
HDACs and the up-regulation of DNMT3a, HDAC2 and KDM5A may identify 
additional targets for the prevention of ethanol-induced apoptosis and FASD.    
 Determination of the synergistic pro-apoptotic effects of epigenetic 
modulators, DNMTs, HDACs and KDM in ethanol-exposed hNCCs.  
     The results from our studies present in this dissertation have clearly shown that 
an increase in the activity of DNMTs and up-regulation of DNMT3a contribute to 
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ethanol-induced apoptosis in hNCCs by resulting in hypermethylation at the 
promoters of the anti-apoptotic genes and repressing the expression of these 
genes.  We have also shown that an increase in the activity of HDACs and up-
regulation of HDAC2 in ethanol-exposed hNCCs resulted in the reduction of the 
acetylation at the promoter regions of the anti-apoptotic genes, which also leads 
to apoptosis. In addition, ethanol-induced up-regulation of KDM5A also contributes 
to ethanol-induced apoptosis by modulating the histone methylation at the 
promoters of Snail1. However, how these epigenetic modulators work together to 
induce apoptosis in ethanol-exposed hNCCs is not clear. Determination of the 
synergistic pro-apoptotic effects of DNMTs, HDACs and KDMs would be another 
important future direction.    
 Summary and conclusions 
      FASD is among the most devastating consequences of the widespread use 
and abuse of alcohol. Growing evidences suggest a major contribution of 
apoptosis to ethanol-induced teratogenesis. This discovery suggests that 
therapeutic strategies directed against apoptosis are particularly valuable for the 
prevention of FASD. Sulforaphane (SFN) is a chemical that is abundant in broccoli 
sprouts and can regulate gene expression through epigenetic mechanisms, 
specifically by decreasing the activities of histone deacetylase and DNA 
methyltransferase. The objective of this work is to elucidate the epigenetic 
mechanisms by which ethanol induces apoptosis and teratogenesis and SFN 
regulates the anti-apoptotic gene expression and prevents ethanol-induced 
apoptosis, and to develop a safe and effective regimen to diminish the incidence 
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and severity of FASD using SFN or SFN-rich broccoli sprouts. Our studies have 
demonstrated that SFN protects against ethanol-induced apoptosis in hNCCs 
through diminishing ethanol-induced hypermethylation at the promoters of the anti-
apoptotic genes. SFN can also prevent hNCCs from ethanol-induced apoptosis by 
diminishing ethanol-induced reduction of histone acetylation at the promoters of 
the anti-apoptotic genes. In addition, SFN protects against ethanol-induced 
apoptosis in NCCs and zebrafish embryos through modulating histone methylation 
and the expression of Snail1 and restoring EMT. Moreover, our studies have 
shown that maternal dietary administration of SFN-rich BSE diminished ethanol-
induced apoptosis and teratogenesis in mouse embryos by epigenetically 
modulating anti-apoptotic genes. These results elucidate that epigenetic silencing 
of the anti-apoptotic genes through promoter hypermethylation and histone 
deacetylation is involved in ethanol-induced apoptosis and teratogenesis and that 
SFN can prevent ethanol-induced apoptosis and teratogenesis by preventing the 
aberrant epigenetic modifications. These findings provide new insight into the 
epigenetic mechanisms underlying ethanol-induced apoptosis, which help to 
define the role of SFN and broccoli sprout extract, a diet-derived epigenetic 
modulator, in the prevention of FASD. These results may establish dietary 
supplementation of broccoli sprout extract as a novel strategy for the prevention of 
human FASD.
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LIST OF ABBREVIATIONS 
 
FASD: Fetal Alcohol Spectrum Disorder 
SFN: Sulforaphane 
DNMT: DNA methyltransferase 
HDAC: Histone deacetylase 
KDM: Histone demethylase 
H3ac: Histone H3 acetylation 
H3K4me3: Trimethylation of histone H3 lysine 4 
NCC: Neural crest cell 
hNCC: human Neural creat cell 
EMT: Epithelial-mesenchymal transition 
KMT: Histone methyltransferase  
HAT: Histone acetyltransferase 
TET: DNA demethylase 
BSE: Broccoli sprout extract 
MSP: Methylated specific PCR 
GD: Gestational Day 
SAM: S-adenosylmethionine 
VPA: Valproic acid 
H3K27me3: Histone lysine 27 trimethylation 
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hESC: human Embryonic stem cell 
HDACi: Histone deacetylase inhibitor 
H3K9ac: histone H3 lysine acetylation at position 9 
TSA: Trichostain 
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